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ABSTRACT
Central line-associated bloodstream infections (CLABSIs) are one of the most
significant healthcare-associated infections (HAIs) in the Intensive Care Unit (ICU)
setting resulting in increased lengths of stay, increased healthcare costs, and higher
mortality rates (Institute of Healthcare Improvement [IHI], 2012). Evidence that
CLABSIs are largely preventable has created opportunities for healthcare organizations
to implement evidence-based bloodstream infection prevention practices to reduce or
eliminate these infections (Lissauer, Leekisa, Prease, Thom, & Johnson, 2012). Other
efforts to reduce CLABSIs include implementation of safety programs to improve the
safety culture in ICUs (Lissauer et al., 2012). One program, the comprehensive unitbased safety program (CUSP), was developed to improve the safety culture within ICUs
and achieve the goal of reducing or eliminating CLABSIs (Pronovost et al., 2006). The
CUSP is a framework designed to educate and improve awareness of patient safety and
quality of care for nurses, physicians, and other bedside care providers through a five step
process (Agency for Healthcare Research and Quality [AHRQ], 2011). The five steps of
the CUSP program are: (1) educate on the science of safety; (2) identify defects and
patient safety hazards; (3) partner senior executive with a unit; (4) learn from defects; and
(5) implement teamwork and communication tools (AHRQ, 2011).
The seminal study by Pronovost et al. (2006) was conducted with a focus on
reducing CLABSIs and improving the safety culture in 108 ICUs within the state of
Michigan. The study intervention targeted the use of bundled evidence-based
bloodstream infection prevention practices in conjunction with implementation of the
CUSP (Pronovost et al., 2006). The study results demonstrated a 66% decrease from
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baseline in the statewide CLASBI rates with continued sustainment at 18 months
(Pronovost et al., 2006). Success of this seminal study and others resulted in a national
program called On the CUSP: Stop BSI formulated to reduce or eliminate CLABSIs in
hospitals nationwide (AHRQ, 2012). More than 1,000 hospitals participated in this
program and achieved success in reducing nationwide CLABSI rates by 41% (AHRQ,
2012).
The reduction of CLABSIs through multiple collaborative cohort studies has been
attributed to the use of evidence-based prevention bundles and improvement in the
healthcare safety culture. The CUSP framework has been validated as an essential factor
in the success of CLABSI reduction efforts. Continued progress in the reduction of
CLABSIs emphasizes the preventability of these infections and will accelerate progress
toward elimination.
The purpose of this project was to reduce or eliminate CLABSIs in the ICUS
within our national investor-owned 49 hospital healthcare system through the
implementation of the CUSP framework. The impact of the CUSP was evaluated using a
pre-and post-implementation comparison of hospital CLABSI rates. Data was reported
for 65 ICUs, representing 41 hospitals across the baseline pre-and post-CUSP
implementation time periods. The total number of CLABSIs reported for the baseline
pre-CUSP implementation time period of September 2012 to January 2013 was 71, with
an infection rate of 1.10 per 1,000 catheter days. The data for the post-CUSP
implementation time period of August 2013 to December 2013 revealed a decrease in the
total number of CLABSIs to 42, and a resultant decrease in the infection rate to 0.73 per
1,000 catheter days. This decrease represented a 32.8% reduction in CLASBIs post-
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CUSP implementation. The evaluation of the CUSP implementation success through the
reduction or elimination of CLABSIs validated the potential replication of a systematic
approach to address additional quality improvement (QI) initiatives throughout our
healthcare system.
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CHAPTER I – INTRODUCTION AND PROBLEM STATEMENT
Introduction
Central venous catheters (CVCs) are integral to the care of adult patients in
Intensive Care Units (ICUs). CVCs provide vascular access for the administration of
fluids, medications, total parenteral nutrition (TPN), blood products, and for
hemodynamic monitoring and blood sampling (Kim, Holtom, & Vigen, 2011).
Approximately 48% of all patients in ICUs have CVCs which translates into an estimated
15 million catheter days per year (Centers for Disease Control and Prevention [CDC],
2011). Although CVCs provide reliable vascular access, there are associated risks with
their use. The most common risk associated with CVCs is central line-associated blood
stream infections (CLABSIs) caused by microorganisms colonizing the external surface
of the device or the fluid pathway when the device is inserted, or in the course of its use
(Institute for Healthcare Improvement [IHI], 2012). CLABSIs are defined as laboratoryconfirmed bloodstream infections associated with CVCs when a CVC has been in use 48
hours prior to the onset of an infection with no apparent source except the CVC (O‟Grady
et al., 2011). In 2009, approximately 18,000 CLABSIs occurred in ICU patients with
CVCs (CDC, 2011). According to the IHI (2012), approximately 90% of all CLABSIs
occur due to CVC use, resulting in increased lengths of stay, increased costs, and higher
mortality rates. CLABSIs are one of the most significant healthcare-associated infections
(HAIs) in the ICU setting, representing 10% to 20% of all HAIs (Bianco, Coscarelli,
Nobile, Pileggi, & Pania, 2013). These infections are the leading cause of death among
HAIs with reported mortality rates of 12% to 25% in adult ICU patients (Marra et al.,
2010). CLABSIs are a significant source of preventable morbidity and mortality
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responsible for approximately 28,000 deaths annually in the United States (Lissauer,
Leekisa, Preas, Thom, & Johnson, 2012). In addition, CLABSIs represent a significant
economic burden for healthcare organizations, prolonging a patient‟s hospitalization an
average of seven days with an episodic cost of approximately $45,000 (Lissauer et al.,
2012). The estimated annual cost of CLABSIs to the healthcare system in the United
States is $2.3 billion (Pronovost, Marsteller, & Goeschel, 2011). As a result of these
findings, The Joint Commission (TJC) mandated hospitals to implement protocols by
January 1, 2010 that meet the requirements of the CLABSI national patient safety goal
(NPSG) 7, the reduction of CLABSIs (TJC, 2010).
Evidence that HAIs are largely preventable has created opportunities to
implement practices to reduce or eliminate the burden associated with such infections.
CLABSIs are customarily preventable with adherence to evidence-based preventative
guidelines (Kusek, 2012). As such, many healthcare organizations have undertaken
efforts to reduce the incidence of CLABSIs to include the use of evidence-based central
line insertion bundles (Lissauer et al., 2012). The IHI (2012) defines a care bundle as a
set of three to five practices that have been proven to improve patient outcomes when all
components are completed together every time. Care bundles can benefit patient care by
delivering evidence-based practices to the bedside and ensuring uniform application of
best practices to all patients (McPeake, Cantwell, Booth, & Daniel, 2012). Bundle
approaches are broadly accepted as the standard model for prevention of CLABSIs with
concentrated strategies on physician and patient preparation (Worth & McLaws, 2012).
The five evidenced-based procedures recommended by the CDC and identified as having
the lowest barriers to implementation and the greatest effect on the rates of CLABSIs are
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(1) hand hygiene prior to catheter insertion; (2) use of maximal sterile barrier
precautions; (3) chlorhexidine for skin antisepsis; (4) avoidance of the femoral site for
insertion; and (5) prompt removal of catheters when no longer indicated (Agency for
Healthcare Research and Quality [AHRQ], 2013).
Other efforts to reduce the incidence of CLABSIs, in addition to the use of
evidence-based central line insertion bundles, include the implementation of safety
programs to improve the safety culture within ICUs (Lissauer et al., 2012). One program,
the comprehensive unit-based safety program (CUSP), was designed to improve the
safety culture and includes communication and teamwork toward the common goal of
eliminating CLABSIs (Pronovost, 2008). The CUSP program provides a pragmatic
framework and tools that caregivers at the unit level can utilize to improve teamwork and
relationships with senior hospital executives, to identify and resolve safety hazards, and
to foster a culture of safety (Pronovost et al., 2008).
Although attempts to reduce the incidence of CLABSIs have been successful,
CLABSIs continue to be identified (Marra et al., 2010). CLABSIs represent a principal
challenge that result in significant morbidity, mortality, increased length of stay (LOS),
and economic losses (Bianco et al., 2013). Reducing CLABSI rates in an ICU setting is a
complex process that involves multiple performance measures and interventions (Marra
et al., 2010).
Problem Statement
This project was conducted in a national investor-owned corporation comprised of
49 acute care hospitals and various other comprehensive healthcare services including
ambulatory surgery centers, free-standing emergency departments, urgent care centers,
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and diagnostic centers. Despite the implementation of central line bundles within our
healthcare system, the CLABSI rates continued to prevail. Of the 49 acute care hospitals,
41 have CLABSI rates at greater than the system wide established target of 0.31 per
1,000 device days. This target is set at the standardized rates for CLABSIs in accordance
with the CDC and through the National Health and Safety Network (NHSN) top 25th
percentile benchmark (Dudeck et al., 2011). Although the use of evidence-based
bloodstream infection prevention practices has reduced the number of CLABSIs in our
ICUs, they have not been eliminated. Previous studies have been unable to determine if
these remaining CLABSIs represent failures of the evidence-based bundle application or
other patient associated risk factors related to their hospitalization (Lissauer, Leekisa,
Preas, Thom, & Johnson, 2012). Baseline random observations of the evidence-based
bundle utilization revealed inconsistent application and compliance in several of the ICUs
within our healthcare system. Attempts to develop a valid and feasible measure of
consistent compliance with evidence-based practices for CVC insertions have not been
successful (Pronovost, Berenholtz, & Needham, 2008). CVCs are often placed randomly
which makes the coordination of independent observations difficult, and self-reported
compliance often overrates performance (Pronovost, Berenholtz, & Needham, 2008).
Sustainment of lower CLABSI rates and progression toward elimination will require a
focused commitment of our healthcare system hospitals.
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CHAPTER II – REVIEW OF THE LITERATURE
CLABSI Multifaceted Intervention Studies
There have been many studies documented in the literature regarding the
reduction of CLABSIs in ICUs nationwide. The majority of the studies have reported
statistically significant decreases in CLABSI rates post-implementation of a quality
improvement (QI) initiative (O‟Grady et al., 2011). Some studies used approaches in
which multiple strategies have been implemented together to improve compliance with
the use of evidence-based guidelines. A seminal study conducted by Pronovost et al.
(2006), known as the Keystone ICU project, included a collaborative cohort of 108 ICUs
within the state of Michigan. The strategies in this study included the use of five
evidence-based bloodstream infection prevention practices for CVC insertions, use of a
checklist to ensure adherence and compliance to proper practices, and implementation of
the CUSP to improve the safety culture (Pronovost et al., 2006). The period required for
the implementation of each intervention was estimated to be three months and all
hospitals started with implementation of the CUSP (Pronovost et al., 2006). Coterminous
with the intervention, the median rate of infection decreased from 2.7 per 1,000 catheter
days at baseline to zero within the first three months after the implementation of the
intervention (Pronovost et al., 2006). The benefit from the intervention was sustained as
the study results revealed a 66% decrease in statewide CLABSI rates from baseline at 16
to18 months post-implementation of evidence-based interventions (Pronovost et al.,
2006). This study also emphasized how technical and adaptive components were needed
to successfully implement a CLABSI prevention initiative (Pronovost, Berenholtz, &
Needham, 2008).
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Identifying methods for the sustainment of results from QI initiatives is important
for the generalizability of research findings. A second collaborative cohort study was
conducted by Pronovost et al. (2010) to evaluate the extent to which the participating
ICUs in the initial Keystone ICU project had continued to sustain reductions in their
CLABSI rates. As the participating Michigan ICUs continued to integrate the evidencebased interventions into practice, the study results revealed that the reduced CLABSI
rates achieved in the initial 18 month post-implementation period were sustained for an
additional 18 months (Pronovost et al., 2010). The median rate of infection remained at
zero for the 18 month sustainability period with an over 60% CLABSI rate reduction at
the end of the 36 month period (Pronovost et al., 2010). Sustainment of the results was
attributed to ongoing feedback of progress through the reporting of infection data,
improvements in the safety culture, maintaining the assembled teams, an assiduous belief
in the preventability of CLABSIs, and continuing staff education (Pronovost et al., 2010).
The results of these two collaborative cohort studies indicate that the broad use of the
evidence-based interventions with achievement of comparable results could reduce the
morbidity and costs associated with CLABSIs (Pronovost et al., 2010).
As results of the success with the seminal Keystone ICU project were
disseminated, other healthcare organizations sought to evaluate and replicate the
multifaceted intervention designed to improve the safety culture and the use of evidencebased bloodstream infection prevention practices to reduce CLABSIs. The Rhode Island
(RI) ICU collaborative was created in 2005 as a QI platform to explore the replication of
the Michigan Keystone ICU project (DePalo et al., 2010). Data was collected from the
23 ICUs in the 11 RI hospitals from January 2006 through June 2008. As in the
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Keystone ICU project, each participating ICU implemented the bundled evidence-based
bloodstream infection prevention practices and introduced the CUSP at the launch of the
collaborative (DePalo et al., 2010). The statewide median rate of infection decreased
from 1.95 per 1,000 catheter days at baseline to zero by March 2008 (DePalo et al.,
2010). Study results revealed the use of a multifaceted intervention was associated with a
74% statewide CLABSI reduction and demonstrated the results achieved in the Keystone
ICU project could be extended and replicated in RI (DePalo et al., 2010).
The first randomized controlled experimental evaluation using a multifaceted
intervention involving a bundle of evidence-based bloodstream infection prevention
practices and the CUSP to improve safety, teamwork, and communication was conducted
in 45 ICUs from 35 hospitals within two Adventist healthcare systems (Marsteller et al.,
2012). The intervention group started in March 2007 and the control group started seven
months later in October 2007, with the study period ending in September 2008
(Marsteller et al., 2012). The median CLABSI rate in the intervention group decreased
from 2.56 per 1,000 catheter days at baseline to zero at the end of the study period
(Marsteller et al., 2012). Similar results occurred in the control group with the median
CLABSI rate decreasing from 1.78 per 1,000 catheter days at baseline to zero at the end
of the study period (Marsteller et al., 2012). This study demonstrated a causal
relationship between use of the CUSP and the evidence-based infection prevention
intervention and reduced CLABSIs in participating ICUs (Marsteller et al., 2012). The
intervention group achieved a 70% reduction in CLABSI rates which were sustained at
19 months post-implementation with similar results replicated in the control group
(Marsteller et al., 2012). This study established that the CLABSI rate reduction through
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the implementation of the CUSP and the use of evidence-based bloodstream infection
prevention practices were sustainable and able to be replicated (Matsteller et al., 2012).
After the replication of the Pronovost and colleagues studies (Pronovost et al.,
2006 & 2010) in the RI ICUs and the two Adventist healthcare systems, the AHRQ
funded and launched this program for implementation and dissemination throughout the
United States (Sawyer et al., 2010). A two-year program called On the CUSP: Stop BSI
was formulated in 2008 to prevent CLABSIs in hospitals nationwide and was organized
as a state or region-level collaborative with centralized education, data collection, and
program management functions (AHRQ, 2012). More than 1,000 hospitals and 1,800
hospital units, representing a total of 44 states, the District of Columbia, and Puerto Rico,
participated in the program (AHRQ, 2012). The program structure included three main
components: (1) a model to translate evidence into practice at the bedside to prevent
CLABSIs; (2) the CUSP to improve the safety culture; and (3) a system to measure and
report infection data (Sawyer et al., 2010). Results of the program revealed success in
reducing CLABSIs nationwide by 41% from a baseline of 1.915 infections per 1,000 line
days to a rate of 1.133 infections (AHRQ, 2012).
With the nationwide success of the On the CUSP: Stop BSI program (AHRQ,
2012), the state of Hawaii embarked on their own study to determine if a national ICU
collaborative to reduce CLABSIs would succeed in the state (Lin et al., 2012). The
study, which began in January 2009 and ended in December 2010, included the CUSP, a
multifaceted intervention approach to CLABSI prevention, and infection rate monitoring
(Lin et al., 2012). Data was collected and reported from 20 ICUs representing 16
hospitals across the state (Lin et al., 2012). The results revealed the overall mean
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statewide CLABSI rates decreased 61% from 1.5 infections per 1,000 catheter days at
baseline to 0.6 at 16 to 18 months post-implementation of the project, reinforcing the
evidence that the On the CUSP: Stop BSI program can succeed in other states and
substantially reduce CLABSI rates in hospitals (Lin et al., 2012).
The success of the initial Hawaii study was the catalyst to conduct a second study
in the state. This cohort study continued the national On the CUSP: Stop BSI program
interventions, extended the program beyond the adult ICUs, and implemented a series of
tools to improve the maintenance of CVCs and sustain the collaborative model (Lin,
Weeks, Holzmueller, Pronovost, & Pham, 2013). A total of 38 clinical areas were
included in this study: the original 20 ICUs, 10 adult medical/surgical units, two
operating room (OR) suites, two pediatric ICUs (PICUs), two neonatal ICUs (NICUs),
and two emergency departments (Eds) (Lin et al., 2013). The 18 month time period for
this phase of study was from January 2011 through June 2012. The CLABSI rates in the
adult ICUs decreased from1.49 infections per 1,000 catheter days at baseline to 0.25 by
the end of this study phase, signifying an 83% decrease for the 36 month study period
(Lin et al., 2013). The CLABSI rates in the non-adult ICUs and the non-ICU clinical
areas decreased from 2.54 infections per 1,000 catheter days at baseline to 0.33 by the
end of this study phase, signifying an 87% decrease in the infection rate (Lin et al., 2013).
The second Hawaii cohort study demonstrated successful extension of the program
beyond the adult ICUs, continued sustainment of decreased statewide CLABSI rates, and
the impact of the CUSP on the statewide ability to reduce infections (Lin et al., 2013).
The successes of the numerous studies conducted on the effects of multifaceted
interventions to reduce CLABSIs, along with the nationwide success of the On the
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CUSP: Stop BSI program (AHRQ, 2012), continued to influence additional healthcare
organizations to seek opportunities to participate in collaboratives designed to reduce
CLABSI rates. The state of Connecticut entered into a study to determine whether the
multifaceted intervention from the Michigan Keystone ICU program could be
implemented in the state with similar impact on ICU CLABSI rates (Hong et al., 2013).
Seventeen ICUs from 14 hospitals within the state participated in the collaborative that
included the multifaceted intervention to prevent CLABSIs, implementation of the
CUSP, and measurement and performance feedback of CLABSI data (Hong et al., 2013).
Participating hospitals and ICUs reported baseline data for May 2008 to April 2009 and
post-implementation data for May 2009 to January 2011 (Hong et al., 2013). The overall
mean (median) CLABSI rates in the 17 ICUs decreased from 1.8 (1.8) infections per
1,000 catheter days at baseline to 1.1 (0) at post-implementation of the intervention in
January 2011 (Hong et al., 2013). The overall mean CLABSI rate was decreased by 41%
which, once again, demonstrated that the Michigan Keystone ICU program could be
replicated with associated reductions in CLABSIs (Hong et al., 2013).
Comprehensive Unit-Based Safety Program (CUSP)
Improving communication, teamwork, and the culture of safety in the ICUs was
an integral part of the success in the CLABSI rate reduction studies and the eventual
sustainment of the gains. These studies incorporated a technical component through the
use of evidence-based practices and an adaptive, innovative component through use of
the CUSP to successfully achieve the results (AHRQ, 2012). The Institute of Medicine
(IOM) report To Err is Human (2000) identified patient safety as a nationwide issue and
indicated improvement endeavors should focus on systems such as technology, practices,
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procedures, and the culture in healthcare organizations. As a result, healthcare
organizations began to implement initiatives to improve patient safety. One major
initiative was the seminal study by Pronovost et al. (2005) to develop, implement, and
validate the CUSP. The program was initially developed as an eight step process
designed to impact the safety climate by staff empowerment and responsibility for safety
in their environment (Pronovost et al., 2005). The eight step process in the program
includes: (1) conduct a cultural survey; (2) educate staff on sciences related to safety; (3)
identify the safety concerns of staff members; (4) senior executive adoption of a working
unit; (5) implement improvements; (6) document results; (7) share stories; and (8) repeat
the cultural survey (Pronovost et al., 2005). A pre-and post-implementation evaluation of
the CUSP in two ICUs at Johns Hopkins Hospital resulted in safety culture improvement
in both units and an associated reduction in ICU length of stay (LOS), medication errors,
and nursing turnover (Pronovost et al., 2005). Based upon these results, the CUSP was
disseminated to other units and clinical areas throughout the hospital with similar results
(Pronovost et al., 2005). The CUSP was subsequently truncated into five sequential steps
to facilitate utilization into the daily routines of staff members (Timmel et al., 2010). The
five sequential steps include: (1) science of safety training; (2) identify safety hazards;
(3) senior executive partnership; (4) learn from defects; and (5) implement teamwork and
communication tools (Timmel et al., 2010).
A second study was conducted to validate the Pronovost et al. study (2005) and to
evaluate the impact of the CUSP on the safety climate in a large ICU collaborative cohort
(Sexton et al., 2011). This study further linked safety climate to clinical and operational
outcomes and demonstrated that safety climate is responsive to interventions (Sexton et
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al., 2011). Study results revealed significant improvements in the safety climate from
42.5% to 52.2% and provided further evidence that use of the CUSP and focused
interventions to reduce bloodstream infections was associated with the resultant
decreased CLABSI rates (Sexton et al., 2011).
In conclusion, the reduction of CLABSIs has been attributed to various factors
including evidence-based prevention bundles, education in prevention efforts, statewide
and national collaborative programs, and improvement in the healthcare safety culture.
The CUSP framework has been demonstrated and validated to be an essential component
of the successful CLABSI reduction efforts. Continued progress in the reduction of
CLABSIs emphasizes the preventability of these infections and will accelerate progress
toward elimination.
Needs Assessment and Description of the Project
Population Identification
The target population identified in this project will include registered nurses
(RNs), physicians, and other healthcare team members who provide direct care to adult
ICU patients with CVCs. Other healthcare team members who provide direct care to
adult ICU patients include nurse practitioners (NPs), physician assistants (PAs),
respiratory therapists (RTs), and nurse technicians (NTs). The patient population
identified in this project will include all adult patients with a CVC in the ICU. The
corporate clinical operations executives of our healthcare system elected to exclude
patients admitted to a Pediatric Intensive Care Unit (PICU), Neonatal Intensive Care Unit
(NICU), or any other clinical department outside of the adult ICUs to mitigate
confounding from multiple settings. This decision was also in congruence with the
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model established for the numerous collaborative cohort studies conducted to reduce
CLABSIs.
Project Sponsor and Key Stakeholders
The patient, as the recipient of care, is the most important stakeholder in this
project. Understanding the needs and potential contribution of all other stakeholders is an
important component of this project. Team building is an essential part of the CUSP
program as this approach empowers healthcare team members and eliminates the
traditional hierarchal decision-making in hospitals (Evans, 2012). The identification and
involvement of senior executive leadership is critical to provide authorization for
potential resources required to assist in the resolution of unit-based patient safety issues
(Evans, 2012). The identified healthcare system sponsor for this project is the Vice
President of Quality. She will work with the project leader, the Doctor of Nursing
Practice (DNP) student and author of this document, to ensure the established project
goals and timeline are met in accordance with the project plan.
In addition to RNs, physicians, and senior executives, involvement and
participation from other healthcare team members as internal stakeholders is needed.
These additional team members and internal stakeholders include NPs, PAs, infection
preventionists (IPs), pharmacists, RTs, quality and safety specialists, nutritionists, and
other ancillary or support staff.
Efforts to eliminate HAIs by external stakeholders have further driven
improvement nationwide. External stakeholders include CMS, TJC, CDC, professional
healthcare organizations, hospital associations, and state or national legislators.
Government agencies and payers have pressured healthcare organizations to reduce HAIs
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through regulations, payment incentives, or reliance on market forces such as reporting
high-quality and low-quality providers to consumers (Pronovost et al., 2011). The
reduction of CLABSIs will be an integral element in the nationwide HAI reduction
efforts.
Organizational Assessment
Early in 2006, our healthcare system instituted a focused plan to reduce or
eliminate four HAIs, one of which was CLABSIs. The CLABSI rates for the healthcare
system were above national established and published rates, effecting patient outcomes,
LOS, and reimbursements. The evidence-based central line insertion bundle was
implemented throughout the healthcare system in conjunction with monthly reporting of
individual hospital bundle implementation achievement. It was evident during the
implementation phase that a change in the culture was needed to not only implement the
evidence-based central line insertion bundle and reduce CLABSI rates, but also to create
a sustainable model for improvement.
Progress in CLABSI rate reduction has continued since the 2006 initial
implementation of the evidence-based bundle approach. However, 41 out of our 49 acute
care hospitals currently have CLABSI rates exceeding the healthcare system internal
target. Preventable HAIs are an important focus of governmental agencies, accrediting
bodies, pay-for-performance proposals, and consumer groups (Sawyer et al., 2010). Our
healthcare system recognized that to reduce CLABSIs, the focus would need to be
consistent compliance with evidence-based practices and improvements in the culture and
teamwork within the ICUs. The CUSP framework was selected for implementation in
our continuing efforts to reduce or eliminate CLASBSs across the healthcare system.
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Team Selection and Formation
The foundation for this project is the assembled unit-based team for each
participating ICU in the project. The individuals that comprise the unit-based teams are
responsible for implementing and sustaining the initiative (AHRQ, 2012). The unitbased team composition of each participating ICU was required to include, at a
minimum, a team leader, physician champion, executive champion, and bedside RNs
from each scheduled shift. CUSP team member guidelines were developed and are
presented in Appendix A.
The recommended project team leader is the ICU Manager/Director. The project
team leader serves as the primary contact within the CUSP team who will organize and
lead the team, articulate the goals of the project, develop decisions using the collective
input of the CUSP team members, promote and facilitate good teamwork, and promptly
disseminate information to the CUSP team members (AHRQ, 2012).
The recommended physician champion is the designated ICU Medical Director or
the ICU Intensivist. The physician champion is charged with advancing the project,
bridging any communication gaps, and securing the buy-in of other physicians to
participate in the CUSP project (AHRQ, 2012).
The recommended executive champion for each unit-based ICU team is the
hospital Chief Nursing Officer (CNO) due to the organizational reporting structure of the
ICU and the essential connection of quality initiatives and outcomes to the role and
responsibility of the CNO in each hospital. The executive champion is the senior leader
who partners with the CUSP team and takes an active role in the CUSP initiative (AHRQ,
2012). The direct link of this senior executive with other hospital executives helps
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guarantee the initiative is taken seriously hospital-wide and the project remains an
organizational priority (AHRQ, 2012). Guidelines to assist CUSP team leaders and
members in key messaging for executive sponsorship are presented in Appendix B.
Engaging staff RNs from each shift will provide the frontline expertise and patient
care knowledge to help sustain the effects and success of the CUSP initiative (AHRQ,
2012). Additional members who would be helpful to involve in the unit-based team
composition include IPs, RTs, pharmacists, quality and safety specialists, and
nutritionists. The unit-based focus of the CUSP provides a manageable approach when
initiating cultural change in an organization (Pronovost et al., 2005).
Scope of the Project
The scope of this project will include the education, training, and implementation
of the CUSP as a catalyst in the reduction or elimination of CLABSIs in the adult ICUs
throughout our healthcare system. The CUSP teams will be developed within the adult
ICUs of the participating hospitals. Use of the CUSP will not be applied in any other
clinical department or QI initiative during the course of this project. All CVCs used for
intravenous fluid, medication, dialysis, or administration of TPN to adult ICU patients
will be included. The CLABSI definition and standard outcome measure of surveillance,
as delineated by the CDC, will be utilized for the identification and evaluation of
CLABSIs throughout the project.
Effects on the Healthcare System
The success of this project will demonstrate that the implementation of the CUSP
resulted in the project goal of reducing or eliminating CLABSIs in the ICUs within our
healthcare system. The national On the CUSP: Stop BSI program integrated methods to
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translate evidence into practice with safety culture improvement methods and a system
for measurement of infection data (Sawyer et al., 2010). This approach illustrates that
implementation of interventions must be tailored to the local hospital setting where
patient care is delivered to recognize and resolve potential patient safety hazards or
untoward outcomes (Sawyer et al., 2010).
CLABSIs, and associated care complications, lead to increases in morbidity and
mortality, LOS, and healthcare costs (DePalo et al., 2010). The estimated costs
associated with CLABSIs are approximately $45,000 per infection (Lissauer et al., 2012).
The literature review revealed multiple studies that have resulted in the significant
reduction of CLABSIs after the implementation of evidence-based strategies inclusive of
the CUSP. The RI ICU collaborative study was able to demonstrate the prevention of 42
CLABSIs reduced ICU LOS by 608 days with cumulative savings of approximately $2M
(DePalo et al., 2010). This project will offer a strategy to improve clinical outcomes,
decrease lengths of stay, and reduce costs of care associated with CLABSIs across our
healthcare system.
The need for evidence-based interventions that ultimately improve patient
outcomes is essential in complex healthcare environments. The success of the CUSP will
validate the future use and replication of a systematic approach to undertake other QI
initiatives throughout our healthcare system.
Mission, Goals, and Objectives Statements
Mission
The mission of this project is to utilize a nationally recognized program, with
proven results in reducing CLABSIs, to engage bedside care providers in improving
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safety processes, communication, and teamwork, with senior leadership support. Further,
introducing and educating teams to the CUSP will advance the sustainability of the
outcome metrics through our quality and safety improvement initiatives.
Goals
The ultimate goal of this project will be to reduce or eliminate CLABSIs across
our healthcare system. Additional goals of this project will be to:
1. Determine the causal effects of the CUSP on the reduction of CLABSIs within
the participating ICUs
2. Determine the association of the CUSP team member webinar attendance to
the reduction in CLASBIs
Objectives
The objectives for this project will be presented and categorized as outcome and
process objectives. The outcome objective of this project will be to:
1. Achieve a 30% reduction in CLABSIs across the healthcare system by the 4th
quarter of 2013
The process objectives for this project will be to:
1. Educate participating ICU teams on the culture of safety and the CUSP
2. Implement the CUSP in all participating ICUs
3. Measure and report the number and rate of CLABSIs for each participating
ICU and system-wide
4. Enforce the utilization compliance of the bundled evidence-based blood
stream infection prevention practices in conjunction with the CUSP education
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CHAPTER III – THEORETICAL UNDERPINNINGS OF THE PROJECT
Theoretical Framework
The use of theoretical frameworks progresses our knowledge of organizational
factors that are central to successful implementation and sustainment of innovations
(Jones, Skinner, High, & Reiter-Palmon, 2013). The theoretical framework used for this
project is Rogers‟ Diffusion of Innovations (Rogers, 2003). According to Rogers (2003),
diffusion is the process in which an innovation is communicated through certain channels
over time among the members of a social system. Innovation refers to an idea, practice,
or object that is perceived as new by an individual or other unit of adoption (Rogers,
2003). Newness in an innovation does not just involve new knowledge, but may also be
expressed in terms of persuasion or a decision to adopt (Rogers, 2003).
The evidence-based central line insertion bundle was not new knowledge for our
healthcare teams, however, the attitudes toward the bundle and the decisions to adopt its
use into practice on a consistent basis define it as an innovation. The implementation of
the CUSP framework as a means to further reduce or eliminate CLABSIs is a new idea or
innovation for the assembled teams within our healthcare system.
Five perceived attributes of innovation diffusion that influence the rate at which
an innovation is adopted include relative advantage, compatibility, observability,
complexity, and trialability, and (Rogers, 2003). The attributes of relative advantage and
compatibility are especially important in explaining the rate of adoption and diffusion of
an innovation (Rogers, 2003). Relative advantage is the degree to which an innovation is
perceived as being advantageous and compatibility is the degree to which an innovation
is perceived as being consistent with the values and norms of potential adopters (Rogers,
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2003). An innovation that is perceived as advantageous and compatible will be more
rapidly adopted and diffused. The relative advantage and compatibility of the CUSP
program was provided through the team education sessions and was an important part of
the message content about this innovation to assist in the diffusion process. Observability
is the degree to which the results are visible to others (Rogers, 2003). The extent to
which potential adopters can observe the adoption of an innovation by others can
determine its success for diffusion (Rogers, 2003). The observability of the CUSP was
accomplished through peer testimonials and national success examples provided by the
program participants during the education sessions. Complexity is the degree to which an
innovation is perceived as difficult to understand and use (Rogers, 2003). It was essential
to equip the CUSP team members with a thorough understanding of the CUSP to
facilitate the adoption of the innovation. Trialability is the degree to which an innovation
can be used prior to adoption (Rogers, 2003). The CUSP team members were provided
opportunities to use the skills and tools acquired throughout the education sessions.
Individuals and groups do not all adopt an innovation at the same time (Rogers,
2003). The adoption within individuals and groups typically follows a normal
distribution which can be described with five adopter categories that assist to explain
variation in adoption: innovators, early adopters, early majority, late majority, and
laggards (Rogers, 2003). These adopter categories are the classifications of individuals
and groups on the basis of their innovativeness, the degree to which an individual or other
unit of adoption is relatively earlier in adopting new ideas than other members of a group
or system (Rogers, 2003). It was important for the project leader and the CUSP team
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leaders to recognize that the assembled teams are composed of an array of individuals
who may differ in their progression and patterns of innovation adoption.
The decision to adopt or reject an innovation is conceptualized in several stages
that occur over time. The Diffusion of Innovations theory proposes that knowledge,
persuasion, decision, implementation, and confirmation are the five stages in the
innovation-decision process (Rogers, 2003). This process is one that individuals and
other decision makers go through as they move from gaining initial knowledge about an
innovation, form their attitude about the innovation, make a decision to adopt or reject the
innovation, implement the new idea, and confirm their decision (Rogers, 2003). The
innovation-decision process explains the individual psychological processes involved
with the change experience and the adoption of an innovation (Rogers, 2003). The model
of five stages in the innovation-decision process is presented in Figure 5 in the
Appendices. The theoretical generalizations of the innovation-decision process integrate
well with the CUSP framework. Partnership with senior hospital leaders and the ICU
teams will help ensure all stakeholders are involved in the change process. Teams were
mentored and educated on methods to facilitate change at the unit level, inclusive of
identifying common barriers, using theoretical and evidence-based strategies.
Diffusion of an innovation is an uncertainty reduction process (Rogers, 2003). As
individuals and other decision makers pass through the innovation-decision process, they
seek information to decrease the amount of uncertainty they may have about an
innovation (Rogers, 2003). Introduction and overview of this initiative, with the specific
objectives and interventions, assisted in providing knowledge and diminished the
uncertainty that may have surrounded this innovation. As uncertainty decreases, the
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decision to adopt an innovation increases (Rogers, 2003). The role of this author was as
facilitator for the assembled CUSP teams and for the innovation diffusion process.
Rogers‟ Diffusion of Innovations theory provided the change management
theoretical framework to facilitate the diffusion and adoption of the CUSP in the
participating ICUs within our healthcare system. The linkage of the perceived innovation
attributes and the innovation-decision process stages of the Diffusion of Innovations to
the CUSP five sequential steps are presented in Table 3 in the Appendices.
Program Framework
The CUSP is a safety culture program that is designed to educate and improve
awareness about patient safety and quality of care, empower staff to take charge and
improve safety in their local workplace units, create partnerships between senior
executive hospital leaders and units to improve organizational culture and provide
resources for unit improvement efforts, and provide tools to investigate and learn from
defects (AHRQ, 2011). The program integrates teamwork, communication, and
leadership to create and support a culture of patient safety. The program employs a
collaborative model in which the key participants are interdisciplinary teams of
healthcare professionals from units or departments within a hospital (Pronovost et al.,
2011). The CUSP is implemented and managed at the unit level and involves frontline
patient care providers who recognize and attempt to prevent patient safety hazards
(AHRQ, 2011). The CUSP is comprised of five steps and is designed to integrate an
evidence-based patient safety structured process into a unit or department (AHRQ, 2011).
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The five steps of the CUSP are (AHRQ, 2011):


Step 1: Educate on the science of safety
o This education emphasizes the basic principles of safe design, the
understanding that safety is part of the work system, and that teams
make prudent decisions with diverse and independent input.



Step 2: Identify defects/patient safety hazards
o The CUSP teams were directed to identify, prioritize, and eliminate
patient safety hazards in their ICUs. The CUSP teams were asked how
the next patient will be harmed in their units and how the harm could
be prevented. The CUSP team members were empowered with the
ability to stop procedures if patient safety is compromised.



Step 3: Partner senior executive with unit
o The senior executive partner reviews the identified patient safety
hazards and ensures the CUSP teams have the resources and support to
implement safety risk reductions and assigns accountability to the
teams to mitigate the hazards.



Step 4: Learn from defects
o The CUSP teams were requested to use a tool to learn from one defect
per month that prompts users to answer what happened, why did it
happen, what was done to reduce risk, and whether the intervention
reduced the risk.
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Step 5: Implement teamwork and communication tools
o The CUSP teams were provided several tools which are mechanisms of
change that can be utilized to improve communication and teamwork
deficits within their ICUs. Examples of the communication and
teamwork tools include the morning briefing, daily goals checklist, and
shadowing.

These five sequential steps outline the progression in which the ICUs can assess,
improve, and evaluate their cultures of safety in efforts to reduce or eliminate CLABSIs.
The CUSP is the program framework upon which this project was based.
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CHAPTER IV – PROJECT AND EVALUATION PLAN
Project Plan
CUSP Project Overview
Our healthcare system entered into a partnership agreement with the Center for
Patient Safety for the provision of the CUSP training, education, and support for the ICUs
participating in this project within our healthcare system. The CUSP is a structured
strategic framework for safety improvement that integrates communication, teamwork,
and leadership to create and support a culture of patient safety that can prevent harms
(AHRQ, 2011). The program features evidence-based safety practices, staff training
tools, standards for consistently measuring infection rates, engagement of leadership, and
tools to improve teamwork among physician, nurses, and other direct care providers in
the ICUs (AHRQ, 2011).
The program is a six-month course, offered through a series of six consecutive
monthly webinars and teleconferences, designed to assist hospitals in implementing the
CUSP to ICU teams for success in the reduction of CLABSIs. The course guides
participants through the process of creating a unit or department-based CUSP team,
evaluating the patient safety culture, educating staff on the science of safety, and
identifying and solving defects. Each step of the CUSP builds on the previous work to
systematically provide frontline patient care providers with the tools, metrics, and
framework to undertake the challenge of QI. The content description and objectives for
each of the six monthly sessions are outlined in Appendix C.
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Setting
The project will occur in adult ICUs within our healthcare system. This
healthcare system is one of the largest investor-owned healthcare delivery systems in the
nation. The healthcare system is comprised of 49 acute care hospitals and over 100
outpatient centers spanning 10 states, employing 57,000 people inclusive of 17,000
Registered Nurses (RNs). The acute care division of this healthcare system includes
hospitals that are critical access, community-based, academic teaching, and large urban
medical centers. All hospitals within the healthcare system were invited to participate in
this initiative. Forty-one hospitals assembled ICU teams to participate in the education,
training, and implementation of the CUSP. The hospitals not participating in this project
have previously implemented the CUSP or are involved in state level Hospital
Engagement Networks (HENs) that address efforts to reduce CLABSIs.
Population of Interest
The population of interest identified in this project includes registered nurses
(RNs), physicians, and other healthcare team members who provide direct care to adult
ICU patients with CVCs. The other healthcare team members identified who provide
direct care to adult ICU patients include NPs, PAs, RTs, and NTs. Additional healthcare
team members included in the population of interest who participate in the care of adult
ICU patients are pharmacists, IPs, nutritionists, and quality and safety specialists. The
patient population identified in this project includes all adult patients with a CVC in the
ICU.
The corporate clinical operations executives of our healthcare system elected to
exclude patients admitted to a Pediatric Intensive Care Unit (PICU), Neonatal Intensive
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Care Unit (NICU), or any other clinical department outside of the adult ICUs to mitigate
confounding from multiple settings. This decision was also in congruence with the
model established for the numerous collaborative cohort studies conducted to reduce
CLABSIs.
Measures, Instruments, and Activities
Checklists are cognitive tools that standardize process elements to facilitate care
delivery, reduce variability, and improve the translation of information among varying
team members (Winters et al., 2009). One strategy adopted by the ICUs within our
healthcare system was the use of a central line insertion care team checklist to ensure
adherence to evidence-based bloodstream infection prevention practices during CVC
insertion (Appendix D). This checklist utilizes the static sequential with verification
format which involves a challenge and response (Winters et al., 2009). A designated
person reads the items on the checklist and each responsible party verifies the completion
of their specific task (Winters et al., 2009). This type of checklist helps to reduce
complexity, create independent redundancies, and ensure the entire team and patients are
certain about expected behaviors (Sawyer et al., 2010). Major components of the central
line insertion care team checklist include four of the five evidence-based bloodstream
infection prevention practices of handwashing, using full barrier precautions, cleaning the
skin with chlorhexidine, and avoiding the femoral site when feasible (Pronovost et al.,
2010). The fifth practice of removing unnecessary catheters is not incorporated into the
checklist for central line insertion as it focuses on optimizing CVC maintenance. The
four evidence-based bloodstream infection prevention practices in the checklist have been
validated by a detailed practice guideline issued by the CDC and categorized on the basis
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of existing scientific data, theoretical rationale, and applicability (O‟Grady et al., 2011).
These components were also validated in the 2006 seminal Keystone ICU project
collaborative cohort study where use resulted in a 66% decrease in CLABSI rates
(Pronovost et al., 2006).
Surveillance standardization is essential within and across all of the participating
adult ICUs to measure the magnitude or impact of prevention strategies on CLABSI rates
(Worth et al., 2009). Standardization should incorporate the data collection technique,
the application of an accepted and valid case definition, and the method of analyzing and
reporting CLABSI rates (Worth & McLaws, 2012). The most prevalent data collection
technique is in accordance with the National Healthcare Safety Network (NHSN)
methodology (Dudeck et al., 2011). The validity and reproducibility of the NHSN
surveillance methodology has been evaluated and is extensively applied within and
outside the United States (Dudeck et al., 2011).
Timeline and Project Tasks
The timeline for this project will extend from January 2013 through March 2014.
A detailed timeline with associated tasks for the entire project is presented in Table 4 of
the Appendices.
Risks and Threats
The identified risks and threats for this project were minimal. The first identified
risk of this project was team member attendance and participation in the six monthly
CUSP webinars and teleconferences. The six-month webinar schedule with dates, times,
and access information was distributed to all identified team members prior to the
initiation of the webinars. In addition, each webinar was recorded and stored in an
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accessible electronic folder for subsequent replay in the event a team member missed a
scheduled session.
The second identified risk of this project was team communication and
collaboration. Frontline staff, especially RNs, are apprehensive about identifying
potentially hazardous situations for fear of repercussion or other barriers (Southworth,
Henman, Kinder, & Sell, 2012). One advantage of the CUSP is its empowerment of
frontline staff to assume responsibility for patient safety by generating issues, prioritizing
them, and implementing them based upon the ICU identified needs (Pronovost et al.,
2005). Enhanced autonomy and communication by RNs alters role expectations of both
nurses and physicians (Southworth et al., 2012). This risk was mitigated through the
provision of the science of safety education which provides a conceptual framework and
a common safety vocabulary that allows frontline staff to recognize, surface, and address
defects at the unit level (Southworth et al., 2012).
Evaluation Plan
The impact of the CUSP on the reduction or elimination of CLABSIs was
evaluated using a pre-and post-implementation comparison of hospital CLABSI rates.
This outcome measure was selected because the CDC provides a standardized definition
of CLABSIs and all of the hospitals within our healthcare system currently collect and
report this data. This standard outcome measure for surveillance is defined as the number
of CLABSIs per 1,000 central line catheter days, where the numerator is the number of
CLABSIs and the denominator is the number of catheter days (O‟Grady et al., 2011).
Data for the numerator and denominator was collected by the IPs at each participating
hospital, independent of the established ICU CUSP teams. Evaluation of the project
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through data collection of CLABSI rates offers accountability to the stakeholders,
demonstrates improvement in quality and outcomes, and provides rationality to the
initiative (Zaccagnini & White, 2011).
Baseline performance was measured using the September 2012 through January
2013 CLABSI rate data for our healthcare system. Baseline performance must be
measured to understand the improvement opportunity and the magnitude of improvement
after implementation of the CUSP (Pronovost, Berenholtz, & Needham, 2008).
Throughout the project, the CUSP teams received monthly feedback on the number of
CLABSIs in the ICUs and quarterly feedback on the CLASBI rates. Frequent monitoring
of outcomes and feedback to the CUSP teams can have a significant impact on the
confirmation stage of the innovation-decision process. During the confirmation stage,
individuals seek to reinforce the innovation adoption decision previously made through
the validation of its impact (Rogers, 2003). The CUSP team training and education was
completed at the end of July 2013. Analysis of the CLABSI rates for August 2013
through December 2013, with comparison to the baseline period of September 2012
through January 2013, will be used to evaluate the effect and success of the project.
Evaluation of the CUSP implementation success through the reduction or elimination of
CLABSIs will provide an opportunity to determine future use and replication in other
clinical units and QI initiatives.
Financial Plan
The costs and professional fees for the delivery of the CUSP training, education,
and support from the Center for Patient Safety will be managed through the funding
provision of the healthcare system corporate offices. Materials for the training sessions
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and webinars will be maintained electronically on the healthcare system intranet share
point site with access for all participating hospitals. Additional expenses for the
participating hospitals in the project will not be incurred. No funding will be necessary
for program evaluation completion.
Institutional Review Board (IRB)
This project includes an education and training program designed for the RNs,
physicians, and other previously identified healthcare team members within our
healthcare system ICUs. This project is a QI initiative without the use of human subjects.
Data used will be de-identified and reported in the aggregate. Because of this project
design, IRB approval is not required. The Biomedical IRB Notice of Excluded Activity
from the University of Nevada, Las Vegas (UNLV) Office of Research Integrity-Human
Subjects is presented in Appendix E.
Maintaining/Sustaining the Change
Sustained reduction or elimination of CLABSIs will require continued efforts.
The seminal Keystone ICU Project demonstrated that the reduction of CLABSIs can be
sustained with ongoing focus and monitoring efforts (Pronovost et al., 2006). The
durability of this effect suggests that not only can behaviors be changed, but education,
engagement, monitoring, and feedback can sustain these gains beyond the intervention
stage (AHRQ, 2013). Increased understanding of the root causes of CLABSIs that do
occur will provide valuable insights that will sustain improvements long term (Clancy,
2012).
To sustain our efforts, the hospitals within our healthcare system will be requested
to formally integrate and incorporate the CUSP into their QI plans and efforts. This will
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include ongoing measurement and feedback of performance, encouragement of the teams
to continue the work, and incorporating the CUSP education into staff orientation. In
addition, plans will be formulated to integrate the CUSP into other clinical areas outside
of the ICUs where CVCs are also inserted.
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CHAPTER V – SUMMARY OF IMPLEMENTATION AND RESULTS
Initiation of the Project
The project was initiated in January 2013 under the direction of the DNP student
and author of this document. All hospitals within our healthcare system with ICUs for
adults were invited to participate in this project. Correspondence was sent to all Chief
Executive Officers (CEOs), CNOs, Quality Directors (QDs), IPs, and Risk Managers
(RMs) with an overview of the CLABSI CUSP project organization, project objectives,
and the dates and times for each of the six consecutive monthly webinars. Hospital
CUSP team membership guidelines were distributed to the CNOs for assignment,
completion, and return. A share point site was created on the healthcare system intranet
as the repository for all CUSP education and training materials. Access to this share
point site was provided for all participating hospitals and CUSP team members.
Communication, coordination, and completion of these items were essential to ensure a
smooth transition into the educational intervention.
Education of the identified hospital CUSP team members was accomplished
through a series of six consecutive monthly webinars and teleconferences beginning on
February 26, 2013 and culminating on July 23, 2013. The webinars were approximately
one hour in duration and focused on an introductory overview of the entire program and
each of the five steps of the CUSP. The format of the webinars included a power point
presentation on one specific component or step of the CUSP program followed by a
question-and-answer period with the teams. Technical support and clinical guidance
were offered through each of the webinars and teleconferences. In addition to the
didactic content of each webinar, hospital CUSP team members were encouraged to
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participate by sharing their successes and challenges to expand their knowledge as they
evolved with implementation of the program. The webinars were designed to prepare the
teams to implement the CUSP and develop a social network of hospitals and colleagues
that learn together during implementation (Della et al., 2012). The creation of this social
community enabled the CUSP team members across all hospitals to mutually reinforce
beliefs about the importance of preventing CLABSIs and fostered synergistic
improvements to reduce these infections (Pronovost et al., 2011).
Providing resources, tools, and support for the CUSP teams to ensure innovation
adoption throughout the course of the project was imperative to effective program
implementation and achieving project objectives. Additional resources and support were
provided for the CUSP team leaders that included team ground rules, team meeting
agendas inclusive of content items for the meeting and facilitation guidance instructions
for the team leaders, staff safety assessment form, attendance sheet for staff safety
training and assessment completion, and the learn from defects tool worksheet. These
documents are provided in the Appendices labeled Appendix F through Appendix O.
Threats and Barriers to the Project
Common barriers to implementation of best practices to reduce or eliminate
CLABSIs include lack of leadership support, lack of a safety culture, and inadequate
education (Kusek, 2012). Leadership support was not an identified barrier in this project.
Education of the CUSP teams was also not an identified barrier because of the designed
instructional intervention that addressed the overview of CUSP and the five sequential
steps of the program. The CUSP is designed to improve the safety culture of a unit
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through increasing awareness of quality care problems and encouraging communication
and teamwork (Lin et al., 2012).
Although these common barriers were not identified in this project, several
hospitals experienced early challenges with the CUSP implementation and the spread of
change throughout the units and to the clinicians. Engaging frontline physicians was an
early identified barrier in the project. This challenge did not significantly delay the
project progress and was addressed individually by the CUSP team physician and
executive champions. Nursing empowerment, a documented advantage of the CUSP,
was also an identified early challenge. Nursing staff reluctance to question or challenge
physicians and other healthcare team members when they observed noncompliant patient
care delivery posed a potential obstacle to achieving the desired outcomes associated with
the CUSP. This risk was mitigated through consistent, supportive leadership
involvement and reinforced by physician, nurse, and executive champions that assisted in
eliminating any dissent and contributed to program success. Teams discovered that safe
dialogue was essential to foster trust, transparency, and program commitment (Lin et al.,
2012).
These identified cultural barriers must be considered and addressed when
attempting to improve the quality and reliability of patient care. An effective
methodology that was employed to assist the teams to address local barriers and impact
change was a “four Es” approach: (1) engage staff in the need to address the problem
and why the interventions are important; (2) educate staff on the evidence supporting the
interventions; (3) execute the intervention activities and practices targeted at the barriers
and challenges; and (4) evaluate the process and outcomes regularly (Pronovost,
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Berenholtz, & Needham, 2008). This approach recognizes the importance of culture
change, contextual factors, engaging staff in the project, and identifying local barriers.
As such, this approach complimented and aligned with the overall framework of the
CUSP and provided structural guidance for the teams to assist in addressing and
overcoming associated project barriers.
Monitoring of the Project
Monitoring of the project implementation and ongoing efforts to measure progress
against the goals and objectives, mission statement, evaluation plan, and timeline was an
important task. Maintaining the momentum of this large-scope project was an essential
element in achieving the desired goals and outcomes. The project required that all of the
team members and stakeholders collaborate, understand the basis of the work and the
sequential progression of the project, and complete the required program tasks. Because
of the sequential nature of the webinars and associated project assignments, it was
imperative to ensure that the CUSP teams progressed collectively and completed the
required actions in the established time frames. Checklists were developed and provided
to each CUSP team leader that outlined the specific actions required of the team for each
of the six webinars and the associated resources to assist in the completion of each action
item. The six checklists are provided as tables in the Appendices labeled Table 5 through
Table10. The actions listed on each checklist were required to be completed by each
CUSP team prior to the next scheduled webinar.
Variation in adoption and completion of the actions required of the CUSP team
members following each consecutive webinar can be associated with the Diffusion of
Innovations framework that describes the five adopter categories of innovators, early
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adopters, early majority, late majority, and laggards (Rogers, 2003). Individual guidance,
support, assistance, and consultation was provided throughout the project for the hospital
CUSP teams, as requested by the CUSP team leader or observed by the project leader, to
facilitate movement through the organizational stages of innovation and complete the
associated program requirements in accordance with the project scope and timeline.
Data Collection
Throughout the project, data on the number of CLABSIs was collected monthly
by the hospital–based IP in accordance with the NHSN methodology and definition of
CLABSIs (Dudeck et al., 2011). Hospital CUSP teams received monthly feedback on the
number of infections and quarterly feedback on the rate of infections per 1,000 catheter
days. The feedback of data to teams is critical in generating peer pressure for change and
compliance and to ensure that continual modification and evaluation of processes have
achieved the desired result (McMullan et al, 2013). One attribute of the Diffusion of
Innovations theory is relative advantage, the degree to which an innovation is perceived
as being advantageous (Rogers, 2003). Timely and frequent feedback on the number and
rate of infections to the team members was a method to demonstrate relative advantage to
assist in the adoption and diffusion of this innovation.
CUSP team member attendance for each of the webinars was tracked by the team
leaders on a webinar attendance form (Appendix P) and submitted to the project leader at
the end of the final webinar in July 2013. Attendance records were utilized to determine
the association between the CUSP webinar attendance and reduced CLABSI rates.
Although the webinars were recorded for playback at a later time, attendance was
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determined based upon documented presence at the webinar on the CUSP team webinar
attendance form, due to the interactive nature and design of the presentations.
Data Analysis
Data was analyzed using the Statistical Analysis Software (SAS) version 9.20 and
Medcalc version 13.0.4.0. Data comparing the months of September 2012 to January
2013 (baseline pre-CUSP implementation) to data from August 2013 to December 2013
(post-CUSP implementation) was analyzed. These time periods were selected to allow
for assessment of the largest sample and to correlate with the pre-and post-CUSP
implementation periods.
Inferential statistical analysis was used in the examination of the data. The
CLABSI rates per hospital were calculated as the average of the CLABSI rates from the
ICUs in the hospital which gives each ICU the same weight and provides information
regarding CLABSI rate reduction for an average ICU in the project. A Poisson
distribution was used to examine the relationship between time since the CUSP
implementation and CLABSI rates. The Poisson analysis was also used to generate an
incidence rate ratio (IRR) to compare pre-and post-CUSP implementation CLABSI rates,
as had been done in previous studies (O‟Grady et al., 2011; Pronovost et al., 2006).
Analysis of infection statistics often employs Poisson distribution on the assumption that
infections occur independently and at random in populations. The Pearson productmoment correlation coefficient I and the coefficient of determination (r2) were used to
explore the association between the pre-and post-CUSP implementation CLABSI rates
and the relationship of CLASBI rate reduction and webinar attendance. All reported P
values of 0.05 or less were considered to indicate statistical significance.
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Giving Meaning to the Data
Results
Data are reported for 65 ICUs, representing 41 hospitals and 113,288 catheter
days across the baseline pre- and post-CUSP implementation time periods. The total
number of CLABSIs reported for the baseline pre-CUSP implementation time period of
September 2012 to January 2013 was 71, with an infection rate of 1.10 per 1,000 catheter
days. The data for the post-CUSP implementation time period of August 2013 to
December 2013 revealed a decrease in the total number of CLABSIs to 42, and a
resultant decrease in the infection rate to 0.73 per 1,000 catheter days. This decrease
represented a 32.8% reduction in CLASBIs post-CUSP implementation. As shown in
Table 1, Poisson 95% confidence intervals were calculated to determine the statistical
significance between the pre-and post-implementation CLABSI rates. The P value of
0.0398 demonstrates a statistical significance was observed between the pre-and postCUSP implementation CLABSI rates.
Pre-CUSP Incidence Rate
1.1005
95% Confidence Interval
0.8595 to 1.3882
Post-CUSP Incidence Rate
0.7394
95% Confidence Interval
0.5329 to 0.9995
Incidence Rate Difference
0.3611
95% Confidence Interval
0.0169 to 0.7053
P-value
P = 0.0398
Incidence Rate Ratio
1.4883
95% Confidence Interval
1.0023 to 2.2347
Table 1. CLABSI Rate Comparison Pre-and PostCUSP Implementation
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Poisson 95% confidence intervals were also calculated for differences between the preCUSP and post-CUSP implementation CLABSI rates for each participating hospital.
Table 11 demonstrates the results of this analysis which is located in the Appendices.
The Pearson product-moment correlation coefficient I and the coefficient of
determination (r2) was calculated to compare each hospital‟s rates with their own rates to
determine if an association existed between the pre-and post-CUSP implementation
CLABSI rates. The Pearson r = 0.131 and r2 = 0.0174 demonstrated a weak positive
linear relationship between these two rates (Figure 1). Only 1.74% of total variation in
post-CUSP implementation CLABSI rates can be explained or accounted for by variation
in the pre-CUSP implementation CLABSI rates. The P value was 0.414 which indicates
there was not a statistical significance in the correlation of these rates.

Post CUSP implemation rate

Pre and Post CUSP Implementation CLABSI Rate per 1000
Device Days (N=41)
12
10
8
6
4
R² = 0.0174
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Pre CUSP implementaion Rate

Figure 1. Individual Hospital CLABSI Rate Comparison Pre-and Post-CUSP
Implementation
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The control chart in Figure 2 displays the trend in CLABSI rates from the 1st
Quarter in 2012 through the 4th Quarter in 2013. Prior to the 1st Quarter in 2013, an
upward trend in CLABSI rates was observed that had prompted the need for this project.
A significant decline in CLABSI rates was observed in the 1st Quarter of 2013 coincident
with the initiation of the CUSP project. A slight increase in CLABSI rates was observed
in the 2nd Quarter of 2013 which was not validated with any particular findings.
Subsequent decreases in CLABSI rates were observed in the last two quarters of 2013
post-CUSP implementation.

Number of Infections / Per 1000 Catheter Days Chart
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Figure 2. CLABSI Rates Trended Comparison 1st Q 2012 – 4th Q 2013
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The Pearson product-moment correlation coefficient I and the coefficient of
determination (r2) was calculated for each hospital, based on CUSP team webinar
attendance forms, to determine the strength of the association between overall webinar
attendance and post-CUSP implementation CLABSI rates. Attendance for each webinar
was calculated based on required attendees and actual attendees. The Pearson r = 0.06
and r2 = 0.0041 demonstrated a weak positive linear relationship between these two rates
(Figure 3). The P value of 0.701 indicated there was not a statistical significance that was
demonstrated in this statistical analysis associated with webinar attendance and CLABSI

CLABSI Rate per 1000 device Days

rate reduction.
Overall Attendance and Post CUSP implementation
CLABSI Rate Correlation (N=39)
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CUSP Webinar Attendance

Figure 3. Overall Webinar Attendance and Post-CUSP Implementation
CLABSI Rates
Given the results of the above webinar attendance analysis, a second analysis was
conducted to determine if there was an association between the degree of webinar
attendance and the reduction of CLABSI rates. The webinar attendance forms were
further divided into three categories of good, fair, or poor based on percentile of team
member attendance. Good attendance was defined as ≥ the 75th percentile, fair
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attendance was defined as the 25th-75th percentile, and poor attendance was defined as ≤
the 25th percentile (Figure 4).

No of Hospitals

Webinar Attendance by Category
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CUSP Webinar Attendance

Figure 4. Webinar Attendance by Category
The CLABSI rates between attendance categories were compared to evaluate if being a
part of one of these categories correlated with infection rate reductions. Pre-and postCUSP implementation CLABSI rates were compared based upon the three determined
attendance categories. The data displayed in Table 2 demonstrated significant reductions
in CLABSI rates post-CUSP implementation for webinar attendance in the fair and good
categories.
Attendance
Category

Pre-CUSP
Post-CUSP
P Value
% Reduction
Implementation Implementation
Period
Period
CLABSI Rate
CLABSI Rate
per 1000
per 1000
Catheter Days
Catheter Days
Poor
1.543
1.520
0.957
1.4%
(27/17491)
(24/15783)
Fair
0.479
0.154
0.034
67.7%
(15/31300)
(4/25879)
Good
1.896
0.890
0.042
53.0%
(22/11603)
(10/11232)
Table 2. Comparison of Pre-and Post-CUSP Implementation Rates by Attendance
Category
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This CLABSI rate reduction was statistically significant in both the fair and good
webinar attendance categories with P values at 0.034 and 0.042 respectively. There was
no significant CLABSI rate reduction observed in the hospitals categorized with poor
attendance and the percent reduction was low. Poisson 95% confidence levels were also
calculated to determine the differences in the webinar attendance and pre-and post-CUSP
CLABSI rate reductions and to determine statistical significance between the two rates.
These results also revealed statistical significance for webinar attendance and CLABSI
rate reduction in the fair and good attendance categories and no significant CLABSI rate
reduction in the poor attendance category. The detailed results of this analysis are
located in Table 12 in the Appendices.
Discussion
CLABSIs are a significant cause of preventable harm that lead to increases in
morbidity and mortality, length of stay, and healthcare costs (Hong, et al., 2013). At the
onset, our healthcare system sought to evaluate whether an improvement in culture,
through the implementation of the CUSP, could result in achieving the established goal of
a 30% reduction in CLABSIs across the participating hospitals in the system.
Comparison of pre-and post-CUSP implementation CLABSI rates revealed a 32.8%
reduction that exceeded the overall project goal, demonstrated a causal association of the
CUSP implementation and the reduced CLABSI rates, and confirmed that a large-scale
project focused on reducing CLABSIs is feasible. There were a total of 25 out of the 41
hospitals (61%) that achieved a CLABSI rate of zero in the post-CUSP implementation
period. However, 12 of the 41 hospitals (29%) had an established CLABSI rate of zero
pre-CUSP implementation. Nonetheless, 13 additional hospitals reported CLABSI rates
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of zero post-CUSP implementation which resulted in doubling the number of hospitals
reporting zero infections by the end of the project. This study demonstrates that
CLABSIs are preventable in ICUs and supports recent studies which suggest that up to
90% of CLABSIs may be preventable (Pronovost et al., 2010).
The interactive design of the webinars that allowed the CUSP team members
across our healthcare system to share successes and challenges established collaboration,
trust, and enhanced teamwork. Two attributes of the Diffusion of Innovations theory are
observability, the ability to observe the adoption of an innovation by others, and
trialability, the ability to experiment (Rogers, 2003). The CUSP teams established a
network where those who had successes were able to share their experiences on what
worked for them, how they achieved the success, and how they adapted the framework to
work within their culture and hospital. Implementation of the CUSP relies on local
accountability and ownership to adopt and adapt this innovation into daily work practices
(Marsteller et al., 2012). As predicted by the Diffusion of Innovations theory, this
interpersonal network assisted in overcoming any barriers in the process of the CUSP
implementation and enhanced the adoption and diffusion of the innovation.
Study Limitations
This study had several limitations. First, we did not separate the efforts intended
to directly improve culture, through the implementation of the CUSP, and the other
prevention strategies and technologies to reduce CLABSIs such as increased compliance
with the central line insertion bundles, physician insertion technique changes, postinsertion maintenance care practice changes, or the use of impregnated dressings or
catheters and chlorhexidine baths. Nevertheless, the CUSP was the main intervention
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used by the teams and improvements in unit culture and clinical outcomes intersected.
Second, organizational and staffing challenges, such as changes in team leadership or
executive sponsors, were not considered in the continued CUSP implementation of the
individual impacted hospitals. These changes are common, often unanticipated, and have
the potential to slow the rate of diffusion with the other team members and the hospital.
The adoption of an innovation by individuals in an organization is more likely if key
individuals are present and willing to support the innovation (Rogers, 2003). Committed
team leadership and visible executive leadership have been demonstrated as key
contributing factors in the success of the CUSP (Koll et al., 2008). Third, participation in
the CUSP to reduce CLASBIs was not a mandated directive from the executives in our
healthcare system. Although we had an 84% hospital participation rate in the project, a
mandatory directive would have provided the CUSP education for the other nonparticipating hospitals which could have been utilized in the spread of this methodology
to other QI initiatives within their organizations. The CUSP has been demonstrated for
application to reduce other types of preventable harm (Pronovost et al., 2011). Fourth,
we did not measure or have a mechanism to determine if team members unable to attend
the live educational webinars went back and reviewed the recorded sessions at a later
time frame. Although not interactive, the translation of knowledge from the webinar
could have been disseminated to these team members. A methodology to gather this
information for future similar initiatives and projects may prove to be beneficial in
determining the impact of education and overall attendance rates. Fifth, hospital size,
complexity of services, patient acuities, and comorbidities were not analyzed as potential
contributing factors impacting the amount and rate of CLABSI reductions associated with

46

the CUSP implementation. Understanding patients who are more at risk for CLABSIs
may allow targeted efforts at prevention and early diagnosis in the highest risk groups
(Lissauer et al., 2012). Finally, we did not collect data for ICU mortality, length of stay,
and costs of care, which limits the ability to determine whether the resulting
improvements in CLABSI rate reductions led to reductions in these outcomes as well.
Conclusion
Although multifaceted interventions to reduce the incidence of CLABSIs have
been demonstrated to be successful, CLABSIs continue to be identified (Lissauer et al.,
2012). The pioneering work of Pronovost and colleagues at Johns Hopkins Hospital and
the consortium of Michigan hospitals, as well as other efforts across the United States,
have confirmed that the effective application of evidence-based practices can have a
profound effect on the incidence of CLABSIs (AHRQ, 2012). This project demonstrated
that an uncomplicated, inexpensive, evidence-based educational intervention, the CUSP,
resulted in a 32.8% reduction in CLABSI rates. Evidence-based educational
programmatic interventions have proven effective in reducing CLASBI rates (Parra et al.,
2010). The progress achieved with this project challenges the difficulty of changing the
culture and practice of medical and nursing staff, which takes time and perseverance.
Programs to improve quality of care must address culture (Pronovost et al., 2011). In this
program implementation, addressing culture occurred at three levels: (1) recognition that
each hospital and ICU are microsystems within which an intervention is implemented; (2)
enlistment of senior leaders to ensure support of the efforts to reduce CLABSIs; and (3)
the creation of a social community within our healthcare system which has helped to
create innovative standards regarding CLABSIs.
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A leading item on the research agenda for QI initiatives is identifying methods
that sustain a successful project (Pronovost et al., 2010). Sustainability is making an
innovation routine, is often ambiguous, and may not always be legitimately separated
from the initial implementation and evaluation of the project (Greenlaugh, Robert,
MacFarlane, Bate, & Kyriakidou, 2004). However, sustainability should be examined
separately from implementation. Continued success in this endeavor will require ongoing
attention, commitment, support, monitoring, and collaboration. The progress achieved in
this project with the reduction in CLABSI rates highlights the preventability of these
infections and provides the framework that can be successfully applied to other QI
initiatives.
Dissemination and Utilization of Results
The initial findings from this project were presented to our healthcare system
corporate QI Council on February 18, 2014. In addition, each hospital was provided with
their individual findings and results from participation in the project. As a result of the
demonstrated success and initial results from this project, our healthcare system has
decided to launch the CUSP program initiative again with an emphasis on catheterassociated urinary tract infections (CAUTIs). The complete findings and results from
this project will be provided in webinar presentations for the healthcare system in the
second quarter of this year. The DNP student and author of this document will plan on
pursuing publishing the project later this year in a peer-reviewed journal.
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Appendix A
CUSP Team Membership Guidelines
 Members of a CUSP team will vary by unit and by focus of the CUSP initiative

 A general rule is to have representation from all types of staff members who provide
direct patient care on a unit.

 At a minimum, the following staff should be on your CUSP team:
1. Team Leader
 Ideally should be a CNS (advanced practice), Unit Nurse
Manager/Director, Unit-based Quality Nurse, or Nurse Educator
 Should have leadership skills, including project management and
communication abilities
 Anticipated Time Commitment: 4-5 hours per month (1 hour of coaching
calls, 2 hours of planning, 1-2 hours of team meetings)
2. Physician Champion
 Anticipated Time Commitment: 3-4 hours per month (1 hour of coaching
calls, 1 hour of planning with Team Leader, 1-2 hours of team meetings)
3. Executive Champion
 Anticipated Time Commitment: 1-2 hours per month (1-2 hours of team
meetings)
 See Appendix B – Key Messages for Senior Leaders – for messages to
assist in the recruitment an executive champion
4. Staff Nurse (from each shift)
 Anticipated Time Commitment: 1.5-2.5 hours per month (1-2 hours of
team meetings, 0.5 hours for education when implementing evidencebased interventions)

 Other potential team members for consideration regarding their involvement in care
on the CUSP unit: Anticipated Time Commitment for each participant is 1-2 hours
per month (1-2 hours of team meetings)
1. Nutritionist, Pharmacist, or Respiratory Therapist
2. Infection Preventionist (recommended for hospitals working on HAI-related
improvement)
3. Quality Manager (recommended)
4. Nurse Manager (if not the Team Leader)
5. Any other staff who is involved in the direct care of patients on the CUSP unit
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Appendix B
Guidelines for Key Messages – Senior Leader Sponsorship
This document can be used to help CUSP team leaders and members communicate with
Senior Leaders about their CUSP team activities
Messages for Senior Leaders from Project Leaders/Nurse Managers/Middle
Managers











My unit/department is engaging in the Basics of CUSP – a comprehensive unit-based
safety program that engages frontline staff with supervisors, managers, and senior
leaders to solve patient safety problems identified on their own unit.
CUSP helps us identify and take ownership of safety improvement.
CUSP was developed by Dr. Peter Pronovost of Johns Hopkins University. In 2005,
over 100 ICUs in the state of Michigan nearly eliminated central line associated blood
stream infections (CLABSIs), and have held a mean rate of zero CLABSIs for over 5
years.
The CUSP model is proven to be effective, and can be implemented in any unit to
identify and resolve all types of defects while improving patient safety culture on the
unit.
CUSP has five simple steps. We are working through these steps in six monthly
training sessions with Tenet and the Center for Patient Safety. Here are the steps of
CUSP:
1. Form a unit CUSP team with executive sponsorship
2. Educate staff on the Science of Safety
3. Identify defects using the Staff Safety Assessment (“How will the next patient
be harmed? What can be done to prevent that harm from happening?”);
prioritize defects
4. Learn from one defect per quarter
5. Implement team/communication tools
We need your help! CUSP was designed to have an “executive sponsor” – someone
like you who will be part of our team, work with us, and help us if we run into
problems that need executive support. For example, if we find that _<falls>__could
be eliminated or significantly decreased by changing the type of _<enter
supply/equipment here>___ then someone like you could help us with that; Or, if we
identify that the next patient will be harmed on our unit due to pharmacy or lab
issues, you can help us navigate how to get the right people involved to help us fix the
problem.
Staff members on our unit want you to visit us– to round and let our co-workers and
patients know that you are supporting our work to make our unit as safe as possible.
It is a significant morale booster, a personal touch for our patients, and can help us get
the changes we need put in to place.
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Messages for Senior Leaders from Bedside Staff – ‘How you can help me to my job
better”






I love being a <nurse, RT, etc…> and taking care of my patients.
Sometimes it‟s hard for me to do that because of <insert one small issue here:
missing equipment; lost lab tests; late food trays; etc… >
Our unit is learning about a safety program called CUSP and it is teaching us how to
identify problems on our unit and fix them (by asking ourselves, “How will the next
patient be harmed?”) – But some problems can only be fixed outside of our unit.
Our manager does what he/she can to help with these problems, but sometimes he/she
cannot remove the barriers to fully solve the problem.
I want our patients to be safe, to get them well and sent home as soon as possible. I
want to know my family or I will be safe being cared for here. Will you help us make
that happen?
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Appendix C
CUSP Course Content and Objectives
Session 1: Overview of CUSP
Content Description:
Review the components of the CUSP: science of safety education, measure safety
culture, staff safety assessment, learn from defects, and teamwork and
communication tools.
Objectives:
At the end of this session the learner will be able to:
1. Discuss the five components of the CUSP
2. Define how to form a CUSP team
3. Discuss three strategies to engage the executive
Session 2:

Science of Safety and Staff Safety Assessment

Content Description:
Review the science of safety, including how errors happen and the role of the
healthcare provider.
Objectives:
At the end of this session the learner will be able to:
1. Discuss 3 reasons medical errors happen
2. Discuss an example of process redesign to decrease medical errors
Sessions 3 and 4: Learning from Defects (LFDs)
Content Description:
Review the process for learning from defects and define the strategy to identify
defects.
Objectives:
At the end of this session the learner will be able to:
1. Discuss the components of the LFDs process
2. Understand how to identify and prioritize defects
3. Select a defect to apply the LFDs process
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Session 5: Understanding the Results of the Hospital Survey on Patient Safety
Content Description:
Review the AHRQ survey components. Discuss what the results mean and
develop action plans to improve in areas where score is less than 60% positive.
Objectives:
At the end of the session the learner will be able to:
1. Define the different components of the AHRQ survey
2. Understand the results from the AHRQ survey
3. Define 1-2 strategies to address areas on the AHRQ survey that are less than
60% positive

Session 6: Introduction to CUSP Teamwork and Communication Tools
Content Description:
Review different strategies to improve teamwork and communication tools.
Objectives:
At the end of the session the learner will be able to:
1. Share three communication and teamwork tool strategies
2. Discuss strategies to implement at least one of the tools
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Appendix D
Central Line Insertion Care Team Checklist

New line
Rewire




Pt Name_________________ MR# ________________Unit ______________Date/Time ________
Rewire



The purpose of this checklist is to check the procedure and environment before, during and after the procedure. If there
is a deviation in any of the critical steps, immediately notify the operator and stop the procedure until corrected. If a
correction is required, make a check in the „Yes with reminder‟ column and note what correction was made in the
comment space, if applicable. Uncorrected deviation and complications of line placement are to be reported in
hospital-specific incident report. Contact the Attending/ICU Medical Director if any item on the checklist is not
adhered to or with any concerns. PLEASE RETURN COMPLETED FORM TO THE DESIGNATED PERSON
IN YOUR AREA.
Please note that in the absence of contraindications, a chest site is preferred over the femoral due to a lower incidence
of mechanical and infectious complications.
TYPE OF LINE PLACED: _____________________ LOCATION OF LINE: _______________________
# OF LUMENS _____________
Critical Steps

Yes


Yes With
Reminder

Procedure Deviation?
(complete incident report)

Comments:

Before the procedure, did the operator (person inserting line):
Explain the procedure to the patient and provide educational materials
as appropriate. After the patient has been given an opportunity to ask
questions to the individual performing the procedure, ensure informed
consent is provided by the physician.

STOP

Obtain consent for the procedure (signed and witnessed)

STOP

Perform a time-out and document on hospital form

STOP

Confirm hand washing/sanitizing immediately prior

STOP

Operators(s): wear cap, mask, sterile gown/gloves, and eye
protection?

STOP

Assistant: wear cap, mask, isolation gown and gloves, eye protection
(if at risk for entering sterile field, use sterile gown and gloves)
Properly position patient to prevent air embolism
For Chest/EJ: Trendelenburg (HOB <0 degrees)
For Femoral or patients where trendelenburg is contraindicated:
supine

STOP

Prep procedure site (chlorhexidine) for 30 seconds, allow to air dry an
additional 30 seconds. (groin prep: scrub for 2 minutes and allow to
dry for 1 minute)

STOP

Allow site to dry
Use sterile technique to drape from head to toe

STOP

Utilize local anesthetic and/or sedation

N/A 

During the procedure, did the operator:
Maintain a sterile field

STOP

Monitor that lumens were not cut

STOP

Clamp any ports not used during insertion (to avoid air embolism,
clamp all but distal port)

STOP

Obtain qualified second operator after 3 unsuccessful sticks (except if
emergent)

STOP

Aspirate blood from each lumen (to avoid air embolism and ensure
intravascular placement)

STOP

Transduce CVP or estimate CVP by fluid column (to avoid arterial
placement)?

STOP

N/A 
N/A 
N/A 

N/A for fluoroscopy procedures 

After the procedure, did the operator:
Clean blood from site using antiseptic agent (chlorhexidine), apply
sterile dressing and apply sterile caps on all hubs

STOP

Verify placement by x-ray (time in SVC/RA junction) (N/A if placed
under fluoroscopy or in the femoral vein)

STOP

Operator: _______________________________________

N/A for fluoroscopy procedures 

Assistant: ________________________________________
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Appendix E
Biomedical IRB Notice of Excluded Activity

Biomedical IRB
Notice of Excluded Activity
DATE: March 22, 2013
TO: Mr. Michael Basinger, Nursing
FROM: Office of Research Integrity – Human Subjects
RE: Notification of IRB Action
Protocol Title: The Reduction of Central Line-Associated Bloodstream Infections
(CLABSIs) in Intensive Care Units (ICUs) Through the Implementation of the
Comprehensive Unit-Based Safety Program (CUSP)
Protocol# 1303-4410M
This memorandum is notification that the project referenced above has been reviewed as
indicated in Federal regulatory statutes 45CFR46.
The protocol has been reviewed and deemed excluded from IRB review. It is not in need of
further review or approval by the IRB.
Any changes to the excluded activity may cause this project to require a different level of IRB
review. Should any changes need to be made, please submit a Modification Form.
If you have questions or require any assistance, please contact the Office of Research
Integrity – Human Subjects at IRB@unlv.edu or call 895-2794.

Office of Research Integrity – Human Subjects
4505 Maryland Parkway • Box 451047 • Las Vegas, Nevada 89154-1047
(702) 895-2794 • FAX: (702) 895-0805
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Appendix F
Team Ground Rules Sample

 Members commit to active and regular participation in meetings and activities.
o All members agree to attend all meetings. When someone cannot attend that person
will contact the team leader 24 hours in advance of meeting, if possible
 Members come to all meetings with assignments completed, prepared to productively
contribute to discussions and decisions
 Meetings will be started on time if at least 80% of team is present
 We will discuss best decision making model for each situation. We will support
decisions made by the group
 We will use data whenever possible as the „ultimate authority‟
 Honest disagreements are welcome as long as people treat each other with respect.
 All members will be given an opportunity to contribute to discussion and decision.
 Members will listen to others, respect their opinions and not interrupt
 Members monitor minutes for key decisions and promptly communicate to the
staff/unit they represent
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Appendix G
CUSP Team Meeting #1 Agenda Sample
This document is a Sample Agenda for the CUSP team leader to customize for the first
CUSP Team Meeting at their organization
Team Meeting 1
Sample Agenda
1. Overview of CUSP (NOTE TO LEADER – please use the slides from Coaching
Call 1 held on February 26, 2013)
2. Physician Engagement module (NOTE TO LEADER – the URL to the audio file
link and slides are provided on team leader checklist)
3. Science of Safety Video – (NOTE TO LEADER – the URL for the audio file and
slides are on the team leader checklist)
4. Plan to educate all unit staff on the Science of Safety using the URL link to the
video or the DVD. (NOTE TO LEADER – the URL for the video and slides are
on the team leader checklist)
Consider providing the CUSP education as follows:
5.

During regularly scheduled staff meetings
Set up a computer in a designated location with a shortcut on the Desktop of
the computer to CUSP materials
During shift huddles (consider dividing the video content into small segments
to view at different huddle sessions)

Documentation of who attends the CUSP training?
-

Work with your education department to meet facility requirements

6. How will you educate future unit staff members on the Science of Safety?
Consider the following –
- New employee unit orientation
- Assigning a preceptor for new staff to share components of CUSP
- Include in annual competencies
7. Adjourn
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Appendix H
CUSP Team Meeting #1 or #2 Agenda Sample
This document is a Sample Agenda for the CUSP team leader to customize for the first or
second CUSP Team Meeting at their organization
Team Meeting 1 or 2
Sample Agenda
Recommended Documents for Team Meeting:
From Coaching Call 1, 02/26/2013 (if this is your first team meeting):
 The Basics of CUSP Session 1 PowerPoint Presentation (to provide an
overview of CUSP to team)
From Coaching Call 2, 03/26/2013:
 Document - The Basics of CUSP Session 2 PowerPoint Presentation (to
provide an overview of the Staff Safety Assessment and HSOPS)
 Document – Team Ground Rules Sample
 Document – Staff Safety Assessment
 Document 6 – Science of Safety Training Sample 1
 Document 7 – Science of Safety Training Sample 2
1. Overview of CUSP (can use slides from Coaching Call 1 on 02/26/2013)
2. Discuss and set Team Ground Rules (see Document 2 for sample rules)
3. Listen to the Physician Engagement module (audio file link and slides on team
leader checklist from Coaching Call 1, 02/26/2013) – can do this together during
team meeting or individually
4. View the Science of Safety video (audio file link and slides on team leader
checklist from Coaching Call 1, 02/26/2013) – can do this together during team
meeting or individually
5. Develop plan for educating all unit staff on the Science of Safety and
administering the Staff Safety Assessment
6. Plan to educate all unit staff on the Science of Safety using the URL link to the
video or the DVD. (NOTE TO LEADER – the URL for the video and slides are
on the team leader checklist from Coaching Call 1 on 02/26/2013 )
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Consider providing the CUSP education as follows:
During regularly scheduled staff meetings
Set up a computer in a designated location with a shortcut on the Desktop of the
computer to CUSP materials
During shift huddles (consider dividing the video content into small segments to
view at different huddle sessions)
a.

b.

Choose a method to do the Staff Safety Assessment
i.
Can be done immediately following staff education on the Science
of Safety (recommended)
ii. How will the staff assessment forms be collected?
1. Box on the unit that staff puts the survey into
2. Other method?
iii. Who on the CUSP team will collect and collate the results?
How will you educate future unit staff members on the Science of
Safety? Consider the following –
- New employee unit orientation
- Assigning a preceptor for new staff to share components of CUSP
- Include in annual competencies

7. Overview of Hospital Survey on Patient Safety – unit culture survey
a. Develop plan to reach the goal of a 60% response rate
i. Getting the word out
ii. Rewards/recognition (this is a good area for your executive
champion to assist)
b. Review HSOPS Timeline
8. Review action items/assign tasks and deadlines
9. Adjourn
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Appendix I
CUSP Team Meeting #2 or #3 Agenda Sample
This document is a Sample Agenda for the CUSP team leader to customize for the second
or third CUSP Team Meeting at their organization
Team Meeting 2 or 3
Sample Agenda
Recommended Documents for Team Meeting:
From Coaching Call 2:
 Document – The Basics of CUSP Session 2 PowerPoint Presentation (to
provide an overview of the Staff Safety Assessment and HSOPS)
 Document – Team Ground Rules Sample
 Document – Staff Safety Assessment
From Coaching Call 3:
 Document – The Basics of CUSP Session 3 PowerPoint Presentation (to
provide an overview of the Revised HSOPS Timeline and the Learning
from Defects Tool)
 Document – Learning From Defects Tools
 Document – Article on Learning from Defects
1. Discuss and set Team Ground Rules (see Document from Coaching Call 2)
2. Collate and prioritize results of the Staff Safety Assessment (Document from
Coaching Call 3 – slides 12-18)
3. Select one defect to take through the Learning from a Defect Tool. Begin the
Learning from a Defect Process (Document from Coaching Call 3 – slides 19-43;
Documents from Coaching Call 3 – Learning from Defects Tools)
4. Homework for all team members – read Document from Coaching Call 3 –
Article on Learning from Defects
5. Review action items/assign tasks and deadlines
6. Adjourn
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Appendix J
CUSP Team Meeting #3 or #4 Agenda Sample
This document is a Sample Agenda for the CUSP team leader to customize for the third
or fourth CUSP Team Meeting at their organization
Team Meeting 3 or 4
Sample Agenda
Recommended Documents for Team Meeting:
From Coaching Call 3, 04/23/2013
 Document – The Basics of CUSP Session 3 PowerPoint Presentation (to
provide an overview of HSOPS and the Learning from Defects Tool)
 Document – Learning From Defects Tool
 Document – Article on Learning from Defects
From Coaching Call 4, 05/28/2013
 Document – Learning From Defects Tool
 Document – Case Summary Learning Tool
1. Collate and prioritize results of the Staff Safety Assessment (Document from
Coaching Call 3 – slides 8-10)
2. Select one defect to take through the Learning from a Defect Tool. Begin the
Learning from a Defect Process (Document from Coaching Call 3 – slides 11-27;
Document from Coaching Calls 3& 4 – Learning from Defects Tool)
3. Complete the Case Summary Learning Tool (Document from Coaching Call 4)
4. Review action items/assign tasks and deadlines
5. Adjourn
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Appendix K
CUSP Team Meeting #4 or #5 Agenda Sample
This document is a Sample Agenda for the CUSP team leader to customize for the fourth
or fifth CUSP Team Meeting at their organization
Team Meeting 4 or 5
Sample Agenda
Recommended Documents for Team Meeting:
From Coaching Call 3,
 Document – The Basics of CUSP Session 3 PowerPoint Presentation (to
provide an overview of the Learning from Defects Tool)
From Coaching Call 4,
 Document – Learning From Defects Tool
 Document – Case Summary Learning Tool
From Coaching Call 5,
 Document – The Basics of CUSP Session 5 PowerPoint Presentation (to
provide the method for patient safety action planning)
1. Select one defect to take through the Learning from a Defect Tool. Begin the
Learning from a Defect Process (Document from Coaching Call 3 – slides 11-27;
Document from Coaching Call 3 – Learning from Defects Tool)
2. Complete the Case Summary Learning Tool (Document from Coaching Call 4)
3. Review HSOPS/patient safety survey results; begin action planning
4. Review action items/assign tasks and deadlines
5. Adjourn
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Appendix L
CUSP Team Meeting #5 or #6 Agenda Sample
This document is a Sample Agenda for the CUSP team leader to customize for the fifth or
sixth CUSP Team Meeting at their organization
Team Meeting 5 or 6
Sample Agenda
Recommended Documents for Team Meeting:
From Coaching Call 4,
 Document – Learning From Defects Tool
 Document – Case Summary Learning Tool
From Coaching Call 5,
 Document – The Basics of CUSP Session 5 PowerPoint Presentation (to
provide the method for patient safety action planning)
From Coaching Call 6,
 Document – The Basics of CUSP Session 6 PowerPoint Presentation (for
an overview of communication/teamwork tools)
1. Complete the Case Summary Learning Tool (Document from Coaching Call 4)
2. Review HSOPS/patient safety survey results; begin action planning
3. Review communication/teamwork tools; plan to implement at least one.
4. Establish a process to Learn from One Defect monthly.
5. Review action items/assign tasks and deadlines
6. Adjourn
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Appendix M
Staff Safety Assessment – CUSP

Purpose of this form: The purpose of this form is to tap into your knowledge and
experiences at the frontlines of patient care to find out what risks are present on your unit
that have or could jeopardize patient safety.
Who should complete this form: All health care providers within the ICU
How to complete this form: Provide as much detail as possible when answering the 2
questions. Drop off your completed safety assessment form in the location designated by
the CUSP improvement team with your job category, date, and unit (name is optional).
When to complete this form: Assessing safety should be considered an iterative
process with no defined end (like a moving bicycle wheel). Thus, it can be filled out by
any health care provider in the ICU at any time. At the very least, all health care
providers should complete this form semiannually.
Name (optional): __________________________________________
Job Category: ____________________________________________
Date: __________________
Unit: __________________
Please describe how you think the next patient in your unit/clinical area will be
harmed.

Please describe what you think can be done to prevent or minimize this harm.

Thank you for helping improve safety in your workplace!
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Appendix N
Attendance Sheet – Science of Safety/Safety Assessment
Unit Name: _____________________________________
Name

Date of Training

Science
of
Safety

Staff
Safety
Assess

___________________________________

____________________

____

____

___________________________________

____________________

____

____

___________________________________

____________________

____

____

___________________________________

____________________

____

____

___________________________________

____________________

____

____

___________________________________

____________________

____

____

___________________________________

____________________

____

____

___________________________________

____________________

____

____

___________________________________

____________________

____

____

___________________________________

____________________

____

____

___________________________________

____________________

____

____

___________________________________

____________________

____

____

___________________________________

____________________

____

____

___________________________________

____________________

____

____

___________________________________

____________________

____

____

___________________________________

____________________

____

____

___________________________________

____________________

____

____
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Appendix O
Learn From Defects Tool Worksheet
Date:
Attendees:
What happened? (brief description)

Why did it happen? (what factors contributed)

+

-

What prevented it from being worse?

What happened to cause the defect?

What can we do to reduce the risk of it happening with a different person?

How will we know the risk is reduced?

With whom shall we share our learning?
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Appendix P
CUSP Webinar Team Attendance List
February – July 2013
Hospital ____________________________
Unit________________________________
Team Member

Webinar
#1
2/26/13

Webinar
#2
3/26/13

Webinar
#3
4/23/13

TL MD -

Notes:
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Webinar
#4
5/28/13

Webinar
#5
6/25/13

Webinar
#6
7/23/13

Appendix Q
Permission
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Appendix R
Figures and Tables
Figure 5. Model of Five Stages in the Innovation-Decision Process

Note. The innovation-decision process is the process through which an individual (or
other decision-making unit) passes from first knowledge of an innovation, to forming an
attitude toward the innovation, to a decision to adopt or reject, to implementation of the
new idea, and to confirmation of this decision. Adapted from “Diffusion of Innovations
(5th Ed.)” by Everett M. Rogers, 2003, p.170. Copyright 2003 by Free Press, A Division
of Simon & Schuster, Inc. Reprinted with permission.
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Table 3
Diffusion of Innovations Linkage to CUSP Steps
CUSP

DIFFUSION OF
INNOVATIONS

DIFFUSION OF
INNOVATIONS

CUSP Steps

Innovation Attributes

Innovation-Decision
Process Stages
Knowledge

Step 1: Educate on the
science of safety

Relative Advantage
Compatibility

Step 2: Identify defects/
patient safety hazards

Relative Advantage
Compatibility

Knowledge
Persuasion

Step 3: Partner senior
executive with unit

Relative Advantage
Compatibility
Observability
Relative Advantage
Observability
Complexity
Trialability
Complexity
Trialability

Persuasion
Decision

Step 4: Learn from defects

Step 5: Implement
teamwork and
communication tools

Knowledge
Persuasion
Decision
Implementation
Decision
Implementation

Innovation Attributes:
Relative Advantage - The degree to which an innovation is perceived as being advantageous
Compatibility - The degree to which an innovation is perceived as being consistent with values and norms
of the
potential adopters
Observability - The degree to which the results of an innovation are visible to others
Complexity - The degree to which an innovation is perceived as difficult to understand and use
Trialability - The degree to which an innovation can be experimented with on a limited basis

Innovation-Decision Process Stages:
Knowledge - Awareness of an innovation and understanding how it functions
Persuasion - Formation of favorable or unfavorable attitudes toward the innovation
Decision - Activities that lead to adoption or rejection of an innovation
Implementation - Putting the innovation into use
Note. Innovation attributes and stages of the innovation-decision process impact the rate
of adoption. Linkage of the innovation attributes and innovation-decision stages to the
CUSP steps. Adapted from Rogers, E. M. (2003). Diffusion of Innovations (5th Ed.). New
York, NY: Free Press.
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Table 4
Detailed Timeline

Time Period


January 2013









February 2013
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Activities
Review, finalize, and sign the Center
for Patient Safety proposal for
training and services to implement
the CUSP
Draft process steps for each
education webinar session and
assign accountability
Determine technology to be used for
the education webinar series
Determine dates and times for
preplanning and post evaluation calls
for each education webinar
Send memo/correspondence to all
Chief Nursing Officers (CNOs),
Quality Directors (QDs), IPs, & Risk
Managers (RMs) regarding the
CLABSI/CUSP initiative
Obtain final September 2012 –
January 2013 CLABSI rates as
baseline data
Send memo/correspondence to all
Chief Executive Officers (CEOs)
regarding the CLABSI/CUSP
initiative
Send team membership form and
request to all CNOs for assignment,
completion, and return
Complete process requirements to
offer continuing education units
(CEUs) to participants for
attendance at education webinars
Create share point site on the
healthcare system intranet to locate
all CUSP education and training
materials
Send share point site link to all
CNOs, QDs, IPs, RMs, and other
CUSP team members

Time Period
February 2013 (continued)









March 2013








April 2013








May 2013
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Activities
Collect and log all hospital CUSP
team membership forms
Review and finalize draft materials
for webinar #1
Post all materials for webinar #1 on
the share point site one week prior to
call
Conduct pre-and post-webinar calls
on 2/11/13 and 2/26/13
Conduct webinar #1 on 2/26/13
Assign “homework” to CUSP teams
Review and finalize draft materials
for webinar #2
Post all materials for webinar #2 on
the share point site one week prior to
call
Conduct pre-and post-webinar calls
on 3/18/13 and 3/26/13
Conduct webinar #2 on 3/26/13
Assign “homework” to CUSP teams
Obtain IRB Exclusion from the
UNLV Office of Research IntegrityHuman Subjects
Review and finalize draft materials
for webinar #3
Post all materials for webinar #3 on
the share point site one week prior to
call
Conduct pre-and post-webinar calls
on 4/15/13 and 4/23/13
Conduct webinar #3 on 4/23/13
Assign “homework” to CUSP teams
Defend DNP Project Proposal at
UNLV on 4/11/13
Review and finalize draft materials
for webinar #4
Post all materials for webinar #4 on
the share point site one week prior to
call
Conduct pre-and post-webinar calls
on 5/13/13 and 5/28/13
Conduct webinar #4 on 5/28/13
Assign “homework” to CUSP teams

Time Period


June 2013







July 2013






August 2013





September 2013





October 2013




November – December 2013
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Activities
Review and finalize draft materials
for webinar #5
Post all materials for webinar #5 on
the share point site one week prior to
call
Conduct pre-and post-webinar calls
on 6/10/13 and 6/25/13
Conduct webinar #5 on 6/25/13
Assign “homework” to CUSP teams
Review and finalize draft materials
for webinar #6
Post all materials for webinar #6 on
the share point site one week prior to
call
Conduct pre-and post-webinar calls
on 7/8/13 and 7/23/13
Conduct webinar #6 on 7/23/13
Conduct follow-up session with all
CUSP teams
Develop process with participating
hospital IPs to provide the number of
CLABSIs in the ICUs to the CUSP
teams each month
Develop plans to incorporate the
CUSP into new employee
orientation
Review 3rd Quarter 2013 CLABSI
rates as a preliminary measure of
progress and success
Review monthly CLABSI rate
numbers from all participating
hospital ICUs
Conduct follow-up session with all
CUSP teams
Review monthly CLABSI rate
numbers from all participating
hospital ICUs
Develop plans to incorporate the
CUSP framework into the corporate
and hospital QI plans for use in other
quality initiatives
Review monthly CLABSI rate
numbers from all participating
hospital ICUs

Time Period


January 2014






February 2014





March 2014
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Activities
Conduct follow-up session with all
CUSP teams
Review monthly CLABSI rate
numbers from all participating
hospital ICUs
Obtain and review August December 2013 CLABSI rates
Begin data analysis process by
comparing pre-and postimplementation CLABSI rate data
Complete data analysis and
interpretation of pre- and postimplementation of CLABSI rates
Begin evaluation process with
identification of findings
Present findings to corporate
leadership and hospitals system wide
Complete final DNP Project writing
and submit to Project Chair and
Committee Members
Defend final DNP Project at UNLV
on March 24, 2014
Submit approved final DNP Project
to the Graduate College of UNLV

Table 5
Team Leader Checklist – Webinar #1
ACTIONS
 Choose a unit in your hospital to
implement CUSP

RESOURCES



 Recruit a unit-based CUSP team



 Recruit an executive sponsor
 Schedule CUSP team meetings –
once or twice per month
 Listen/view the “Physician
Engagement” module






 Consider listening/viewing one of
the “Science of Safety” videos



 Facilitate first team meeting (for
teams that are established this
month)




 Team members listen/view the

Physician Engagement module and 
the Science of Safety video


The unit may be designated by your
organization for participation in the Basics of
CUSP project.
If not, consider units that have strong
leadership, passion and commitment to
improve the culture for safety and teamwork
on their unit. Also consider units that have a
need to improve aspects of clinical safety.
Document - Recommendations for Unit-based
CUSP Teams
Document – Key Messages for Executives
Schedule team meetings for at least 6 months
for the Basics of CUSP series.
Link to Audio File:
http://www.ahrq.gov/cusptoolkit/videos/02e_p
hys_engagement/index.html
Link to Slides:
http://www.ahrq.gov/cusptoolkit/2assembletea
m/assembleteamnotes.htm#slide15
Science of Safety Videos:
http://www.ahrq.gov/cusptoolkit/videos/04a_s
cisafety/index.html
http://dukepatientsafetycenter.com/video.asp
CUSP Team meeting to be held prior to the
Basics of CUSP Session #2
Document – Sample Agenda for your CUSP
Team Meeting 1
See links to audio files/slides above
If your first team meeting is happening this
month, can view as a group
If first team meeting will be next month,
consider asking team members to view
individually

*In order to stay on track during this 6-month course, actions listed on the Team Leader Checklist should
be considered homework,” to be completed prior to next month‟s coaching call.
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Table 6
Team Leader Checklist – Webinar #2
ACTIONS

RESOURCES

 Complete any action items that
you did not complete on the Team
Leader Monthly Checklist for
Coaching Call 1
 Facilitate team meeting 1 or 2
(depending on whether you had
your first team meeting last
month)







 Roll out Science of Safety
Training and the Staff Safety
Assessment to Unit Staff



 Collate results of the Staff Safety
Assessment



Document – Team Ground Rules Sample
Document – Staff Safety Assessment
Document – Sample Agenda for CUSP
Team Meeting 1 or 2
Document – Science of Safety Training
Sample 1
Document – Science of Safety Training
Sample 2
Document – Attendance Sheet for
Science of Safety Training
You will be instructed on what to do with
your collated results during Coaching Call
3

*In order to stay on track during this 6-month course, actions listed on the Team Leader Checklist should
be considered “homework,” to be completed prior to next month‟s coaching call.
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Table 7
Team Leader Checklist – Webinar #3
ACTIONS
 Complete any action items that
you did not complete on the
Team Leader Monthly Checklist
for Coaching Call 2
 Facilitate team meeting 2 or 3

(depending on whether you had
your first team meeting)


 Prioritize results of the Staff

Safety Assessment; choose a
defect to take through the

Learning from a Defect Tool
 Begin working through the

Learning from a Defect Tool
(we will cover this step in
Coaching Call 4 as well)



RESOURCES

Document – Sample Agenda for CUSP Team
Meeting 2 or 3
Document – Learning From Defects Tools
Document – Article on Learning from Defects
Document – Coaching Call 3 Presentation (slides
12-18)
Document – Sample Agenda for CUSP Team
Meeting 2 or 3
Document – Coaching Call 3 Presentation (slides
19-43)
 Note: “Summarize and Share Findings” (slide
40) will be covered during Coaching Call 4 (do
not do this month)
Document – Sample Agenda for CUSP Team
Meeting 2 or 3
Document – Learning From Defects Tool

*In order to stay on track during this 6-month course, actions listed on the Team Leader Checklist should
be considered “homework,” to be completed prior to next month‟s coaching call.
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Table 8
Team Leader Checklist – Webinar #4
ACTIONS
 Complete any action items that
you did not complete on the Team
Leader Monthly Checklist for
Coaching Call 3
 Facilitate team meeting 3 or 4
(depending on whether you had
your first team meeting)

RESOURCES






 Finish prioritizing results of the
Staff Safety Assessment; choose a
defect to take through the Learning
from a Defect Tool
 Work through the Learning from a 
Defect Tool

 Complete the Post-Coaching Call 4 
survey


Document – Sample Agenda for CUSP
Team Meeting 3 or 4
Document – Learning From Defects Tool
Document – Case Summary Learning Tool
Document – Sample Agenda for CUSP
Team Meeting 3 or 4
Document – Learning From Defects Tool
Document – Case Summary Learning Tool
This will be emailed to you by Wednesday,
May 29th
Please complete survey by Friday, June 7th

*In order to stay on track during this 6-month course, actions listed on the Team Leader Checklist should
be considered “homework,” to be completed prior to next month‟s coaching call.
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Table 9
Team Leader Checklist – Webinar #5
ACTIONS
 Complete any action items that
you did not complete on the Team
Leader Monthly Checklist for
Coaching Call 4
 Facilitate team meeting 4 or 5
(depending on when you had your
first team meeting)

RESOURCES






 Work through the Learning from a
Defect Tool




 Begin patient safety survey results
action planning




 Complete the Post-Coaching Call
5 survey




Document – Coaching Call 5 Presentation
Document – Sample Agenda for CUSP Team
Meeting 4 or 5
Document – Learning From Defects Tool
(from call 4)
Document – Case Summary Learning Tool
(from call 4)
Document – Learning From Defects Tool
(from call 4)
Document – Case Summary Learning Tool
(from call 4)
Document – Coaching Call 5 Presentation
Your HSOPS or other patient safety culture
survey results
This will be emailed to you on Wednesday,
June 26th
Please complete the survey by July 5th

*In order to stay on track during this 6-month course, actions listed on the Team Leader Checklist should
be considered “homework,” to be completed prior to next month‟s coaching call.
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Table 10
Team Leader Checklist – Webinar #6
ACTIONS
 Complete any action items that
you did not complete on the Team
Leader Monthly Checklist for
Coaching Call 5
 Facilitate team meeting 5 or 6
(depending on whether you had
your first team meeting)

RESOURCES




Document – Presentation for Coaching Call
6
Document – Sample Agenda for CUSP
Team Meeting 5 or 6

 Work through the Learning from a
Defect Tool
 Begin patient safety survey results
action planning



Coaching Call 3 and 4 Resources




 Plan to implement at least one
team and communications tool
 Commit to Learning from One
Defect per Month
 Keep your CUSP team meetings
going!



Document – Coaching Call 5 Presentation
Your HSOPS or other patient safety culture
survey results
Document – Coaching Call 5 Presentation



Coaching Call 3 and 4 Resources

*In order to stay on track during this 6-month course, actions listed on the Team Leader Checklist should
be considered “homework,” to be completed prior to next month‟s coaching call
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Table 11
Poisson 95 % Confidence Intervals by Hospital
Pre-CUSP
Post-CUSP
Hospital
Implementation Implementation
Code
Rate
Rate
BAR
0.801
0.000
CCA
0.000
0.000
CGH
0.000
4.418
CYF
1.381
0.000
DES
1.391
1.357
DHF
0.000
0.000
DHW
0.000
1.733
ECH
0.000
0.000
FLO
1.658
0.000
FRH
2.584
0.000
FRM
0.566
0.000
FVR
1.468
0.000
GBH
1.605
0.000
GSM
1.926
1.313
HAH
2.628
1.361
HIA
1.992
1.749
HNM
5.174
1.637
IND
0.000
0.000
LAK
0.000
0.000
LOM
0.000
0.000
LPX
0.000
0.000
MAN
3.390
0.000
MOD
0.932
0.826
NFR
0.886
0.000
NMC
0.000
0.000
NOS
3.962
2.941
PBG
0.564
0.000
PGH
0.414
1.119
PLA
0.000
10.695
PMC
0.000
0.810
PPH
0.322
0.000
PRV
1.018
0.000
PSH
3.376
4.854
SES
0.000
0.000
SFH
0.918
0.897
SIE
0.000
0.000
SMH
0.291
0.445
SRE
1.927
1.767
SYL
0.000
0.000
TWI
2.445
0.000
WBO
0.000
0.000
System
1.101
0.739
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Difference in
Rates
0.801
0.000
-4.418
1.381
0.034
0.000
-1.733
0.000
1.658
2.584
0.566
1.468
1.605
0.612
1.268
0.243
3.537
0.000
0.000
0.000
0.000
3.390
0.107
0.886
0.000
1.021
0.564
-0.705
-10.695
-0.810
0.322
1.018
-1.479
0.000
0.021
0.000
-0.154
0.160
0.000
2.445
0.000
0.361

Lower
Limit
95 % CI
-0.769
0.000
-9.418
-1.326
-2.166
0.000
-5.130
0.000
-1.592
-2.481
-0.544
-0.193
0.416
-2.227
-3.247
-2.757
-0.037
0.000
0.000
0.000
0.000
-3.254
-1.200
-0.850
0.000
-2.595
-0.218
-2.456
-25.518
-2.397
-0.124
-0.393
-7.273
0.000
-1.432
0.000
-1.197
-2.402
0.000
-2.347
0.000
0.021

Upper
Limit
95% CI
2.372
0.000
0.581
4.088
2.234
0.000
1.664
0.000
4.909
7.649
1.676
3.129
2.794
3.451
5.782
3.243
7.112
0.000
0.000
0.000
0.000
10.034
1.414
2.622
0.000
4.638
1.346
1.046
4.128
0.777
0.769
2.428
4.316
0.000
1.474
0.000
0.889
2.722
0.000
7.237
0.000
0.701

Table 12
CLABSI Rates and Webinar Attendance
Category-Poor Attendance:
Pre-CUSP Incidence Rate
1.5437
95% Confidence Interval
1.0173 to 2.2459
Post-CUSP Incidence Rate 1.5206
95% Confidence Interval
0.9743 to 2.2626
Incidence Rate Difference 0.02303
95% Confidence Interval
-0.8194 to 0.86545
P-value
P = 0.9573
Incidence Rate Ratio
1.0151
95% Confidence Interval
0.5639 to 1.8379
Category- Fair Attendance:
Pre-CUSP Incidence Rate
0.4792
95% Confidence Interval
0.2682 to 0.7904
Post-CUSP Incidence Rate 0.1546
95% Confidence Interval
0.0421 to 0.3957
Incidence Rate Difference 0.3247
95% Confidence Interval
0.0245 to 0.6248
P-value
P = 0.0340
Incidence Rate Ratio
3.1005
95% Confidence Interval
0.9877 to 12.8339
Category- Good Attendance:
Pre-CUSP Incidence Rate
1.8961
95% Confidence Interval
1.1883 to 2.8707
Post-CUSP Incidence Rate 0.8903
95% Confidence Interval
0.4269 to 1.6373
Incidence Rate Difference 1.0057
95% Confidence Interval
0.0345 to 1.9769
P-value
P = 0.0424
Incidence Rate Ratio
2.1297
95% Confidence Interval
0.9677 to 5.0377
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